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ABSTRACT 
 
Carpal Tunnel Syndrome (CTS) is a medical condition (neuropathy) that affects many 
individuals throughout their daily lives. The condition is caused by the compression of the 
median nerve in the carpal tunnel space, with repeated flexion and extension of the wrist 
increasing the risk of developing CTS. At present, there is a lack of CTS assessment tools that 
are easy, accurate, and less expensive to implement than traditional methods to help medical 
professionals, workers and employers identify potential causes of CTS within the workplace. The 
purpose of this study was to provide evidence for the validation of a simple and easy to 
implement carpal tunnel compression assessment tool (CTCAT) to more accurately assess CTS. 
The CTCAT is a portable testing device that can easily be used by medical professionals to assist 
with reducing diagnostic wait times and/or costs associated with CTS. As the CTCAT is a new 
instrument, much of the work in this study involved prototype development. A sample of 19 
participants was used for this study (10 with CTS, nine controls). Participants with CTS must 
have been clinically diagnosed. All participants were over 18 years of age. Physical testing was 
completed with the CTCAT based on the Carpal Compression Test protocol (Durkan, 1991). 
Construct-related evidence of validity was provided by relating the CTCAT to the Boston Carpal 
Tunnel Questionnaire and a 10 point Likert pain scale. The findings were analyzed by using 
correlation techniques (i.e., intraclass and Pearson’s correlations) and measures of internal 
consistency (i.e., Cronbach’s alpha). The outcome of this study revealed that the CTCAT 
produced reliable and valid measures when assessing participants with CTS based on response 
time to symptom onset on two testing dates. This study builds on the research of Durkan (1991) 
for the use of participant response time measures to CTS symptom onset as an avenue to 
diagnose individuals with and without CTS. 
 
Keywords:  carpal tunnel syndrome, carpal compression test, assessment tool, validity 
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CHAPTER ONE- INTRODUCTION 
 
 
Overview 
 
 
Carpal Tunnel Syndrome (CTS) is a median entrapment neuropathy that produces 
symptoms varying from numbness or tingling to burning in the median nerve distribution, being 
the volar and first three and a half digits. It is now well known that focal compression of the 
median nerve at the carpal tunnel leads to the symptoms of CTS caused by injury to both the 
sensory and motor nerves (Wang, 2013). Females, more than males, are affected to a greater 
extent by the neuropathy mainly due to anatomical differences (Love, 2003). As the condition 
worsens, the motor supply of the median nerve is affected, which can lead to general clumsiness 
with the hands when picking objects up and knowing how hard the hand is being squeezed. 
When the motor control of the hand is affected, CTS is in the advanced stages of the disease 
(Love, 2003). 
 
Carpal tunnel syndrome affects mainly middle aged working individuals, and the 
occurrence of CTS is high for individuals working both sedentary (i.e., desk) and active jobs 
(i.e., manual labour) (Silverstein, Fine, & Armstrong, 1987). Carpal tunnel syndrome is most 
commonly associated with rheumatoid arthritis, diabetes, hypothyroidism, estrogen replacement 
therapy (Solomon, Katz, Bohn, Mogun, & Avorn, 1999), oophorectomy (Pascual, Giner, 
Arostegui, Conill, Ruiz, & Pico, 1991), and pregnancy (Stolp-Smith, Pascoe, & Ogburn, 1998). 
Carpal tunnel syndrome symptoms can also be caused by heavy manual work, vibrations, and 
awkward positions of the wrist (Roquelaure et al., 1997; Siverstein et al., 1987; Van Rijn et al., 
2009). Over time, CTS may become more prominent in some work environments than others; 
 
such as clerical work, construction, welding, and other physically demanding positions. The 
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disorder can have a debilitating effect on individuals if proper safety precautions are not taken 
into consideration to avoid strenuous repetitive movements, vibrations, and awkward wrist 
positions. 
 
One way to increase the diagnostic efficacy for CTS claims is through electrodiagnostic 
testing, such as electromyography and nerve conduction studies (Atroshi et al., 2003). This 
assessment method is costly to the healthcare system in Canada, costing $400 per test; and is 
usually associated with long wait times for the patient to see the proper medical professional 
(Fowler, Maltenfort, & Ilyas, 2013). 
 
Currently, there are many CTS self-report questionnaires and few clinical tests that are 
quick and easy to implement to get an idea of both subjective and objective reports of a CTS 
condition. Some of these questionnaires, however, do not deal directly with the hand and wrist, 
which can then lead to improper CTS assessments and diagnoses (Jahedi & Mendez, 2012). In 
addition, CTS self-report questionnaires contain a certain degree of biased information due to the 
subjective nature of the assessment tools. 
 
Based on these concerns, there is a need to develop self-report questionnaires and 
assessment tools with high degree of reliability and validity measures that are easy to use and 
administer in CTS diagnostics to minimize measurement error, healthcare cost and time. 
 
Purpose 
 
 
With these concerns in mind, the purpose of this study was to develop a prototype for a 
carpal tunnel compression assessment tool (CTCAT) and then provide evidence of reliability and 
validity measures for the use of the CTCAT in assessing CTS when compared to the Boston 
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Carpal Tunnel Questionnaire (BCTQ) and a 10 point self-report Likert pain scale. Three research 
questions were developed to address the purpose of the study: 
 
1. How reliable are the measures obtained from the BCTQ with the current data? 
 
2.   Can a 10 point self-report Likert pain scale question be used to assess CTS when 
compared to the BCTQ? 
3.   To what extent is the CTCAT able to assess CTS when compared to the BCTQ 
 
and 10 point self-report Likert pain scale? 
 
 
To address the research questions, the Carpal Compression Test (CCT) protocol (Durkan, 
 
1991) was administered at two different testing sessions held two days apart, where a test of 
normality and a variety of statistical correlation techniques were conducted to analyze the data. 
Question one was answered by conducting Cronbach’s alpha correlations to analyze each testing 
session to examine the internal consistency of the BCTQ measures with the current data. An 
intraclass correlation analysis was also conducted to examine the consistency of participants’ 
responses across replications of the BCTQ. 
 
To answer research question two, a test of normality and intraclass correlations were 
conducted to examine the consistency of participants’ responses when using the 10 point Likert 
pain scale across different administrations of the CCT. A second intraclass correlation analysis 
was conducted to provide evidence of validity for the use of the 10 point Likert pain scale as 
validity criteria to assess participants with CTS when compared to the BCTQ part o ne pain 
scores. Evidence of face validity was also provided through the use of qualitative and 
quantitative measures. The development of the 10 point Likert pain scale was necessary because 
the BCTQ did not measure participant pain during the administration of the test, but rather the 
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pain felt within the last 24 hours before administering the CCT.  More specifically, the 10 point 
Likert pain scale measured participant perceived level of pain before and after the administration 
of the CCT, which allowed for the computation of the amount of pain felt by the participant 
during the administration of the test. This computation was accomplished by subtracting the pre- 
test pain measures from the post-test pain measures. 
 
Lastly, to address research question three, Pearson’s correlations were used to provide 
convergent and discriminant evidence of validity for the use of the CTCAT response time 
measures as an avenue to assess CTS when compared to the 10 point Likert pain scale and 
BCTQ. 
 
Significance 
 
 
Treatment for CTS is costly to the healthcare system, with estimated workers 
compensation claims costing roughly $11, 993 Canadian dollars per claim (Li, Liu, Miyazaki, & 
Warren, 1999), totaling over $33 million Canadian dollars per year in 2001 (Watts, Osei-Tutu, & 
Lalonde, 2003). Given the high incidence of CTS and the associated cost in lost productivity and 
treatment, research that may aid in the accurate assessment of CTS is needed. More specifically 
there is a need to assess the reliability and validity of a proprietary tool (CTCAT) to assist with 
improving assessment and diagnostic measures within the healthcare system. 
 
The use of both self-report questionnaires and objective measures are important in the 
assessment and diagnosis of CTS. There are currently many questionnaires in use to assess and 
diagnose CTS, each focusing on different areas of the upper extremity, and asking a variety of 
questions. It is therefore important to use a specific questionnaire when diagnosing a medical 
condition affecting a particular area of the body. This study serves to build on the 
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implementation of the BCTQ by Levine et al. (1993) as a self-report assessment tool for CTS. 
The BCTQ was used to subjectively assess the participants’ current level of CTS pain and 
discomfort, while the results will be statistically analyzed to ensure the results provided on 
multiple testing dates is both valid and reliable. 
 
As the BCTQ assesses both the pain and difficulty with an individual’s CTS symptoms up 
to 24 hours before assessment, but does not give an estimate of pain experienced from pre- to 
post-test to be used as validity criteria for the CTCAT, there was a need to incorporate a 10-point 
Likert scale item to measure the amount of pain experienced by each participant during the 
carpal compression test. 
 
 
From the theoretical perspective, this study aims to build on the existing research work 
 
by Durkan (1991) for the use of participant response time measures to CTS symptom onset as an 
avenue to diagnose individuals with and without CTS. The CTCAT is a portable device that 
could easily be used by many medical professionals in a variety of medical clinics to assess and 
diagnose patients with CTS. The objective testing measures that do exist are costly, and 
frequently require patients to wait for quite some time to be assessed in the clinical setting either 
for a general appointment or electrodiagnosis appointment. With long wait times for a patient to 
been seen by the proper medical professional comes secondary issues, such as increased 
morbidity and time off work or out of normal activity. As Reuben and Siu (1990) stated, direct 
(objective measures) provide an unbiased measure that may provide more accurate and reliable 
information than self-reports (subjective measures). 
 
In summary, this study builds on the research of both Durkan (1991) and Levine et al. 
(1993), while furthering the development of a subjective pain measure to be used when 
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completing CTS physical tests such as the CCT. This study also aims to provide evidence of 
reliability and validity for an innovative objective testing measure to be used to assess and 
diagnose CTS in the clinical setting. 
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CHAPTER TWO- LITERATURE REVIEW 
 
 
This chapter summarizes and highlights the literature available surrounding CTS and its 
impact on the upper extremity and society as a whole. It expands on the different methods and 
techniques used in diagnosing the disorder, and treatment methods currently used for CTS. 
Lastly, this chapter also aims to review the literature dealing with the reliability and validity of 
assessment tools and the differences between self-report questionnaires and direct measures. 
 
Use of the Upper Extremity 
 
 
As bipedal mammals, humans rely heavily on the upper extremities (shoulder, upper and 
lower arm, wrist and hand) for daily functional activities as simple as picking up a coin to those 
as complex as putting on a pair of shoes and tying them up.  To perform these tasks, humans use 
two main forms of movement skills: fine motor and gross motor movements (Haywood & 
Getchell, 2005). Fine motor skills involve the use of the smaller muscle groups and body parts, 
such as the wrist, hands, and fingers while gross motor skills involve the use of the larger, more 
powerful muscles and appendages of the body such as the core, legs and arms. 
 
Anatomy of the wrist. As depicted in Figure 1, the wrist is composed of eight carpal 
bones, and a band of fibrous tissue called the carpal cartilage or the flexor retinaculum (Love, 
2003), forming the floor and the roof of the carpal tunnel. The carpal tunnel is a confined small 
space that has many moving bones with nerves, blood vessels, ligaments, and tendons passing 
through it. The carpal tunnel serves as a pulley aiding the function of the flexor tendons 
(Netscher et al., 1997). It is no wonder that this congested area is prone to injury and repetitive 
wear and tear that leads to the development of symptoms. The carpal tunnel measures a total of 
five millimeters long by ten millimeters wide, housing the median nerve and nine long flexor 
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tendons (flexor digitorum profundus- four tendons, flexor digitorum superficialis- four tendons, 
flexor policis longus- one tendon, and the median nerve) (Wang, 2013). 
 
 
 
 
Figure 1. The carpal tunnel space and associated anatomical structures. This figure illustrates the 
complexity of the carpal tunnel space. Retrieved from clearpathchiropractic.com 
 
The median nerve is derived from the lateral and medial cords of the brachial plexus and 
 
C6 to T1 nerve roots, which then follow a path close to the elbow by the brachial artery (Wang, 
 
2013). The nerve supplies sensory and motor fibres to the thumb, index, middle finger and half 
of the ring finger of the hand. At the level of the carpal tunnel, the median nerve is composed of 
94% sensory fibers and only 6% motor fibers (Kostopolos, 2004). With such a large percentage 
 
of the nerve supply being sensory, many individuals suffer from sensory deficits such as tingling, 
burning, aching, and general pain in the affected fingers (Atroshi et al., 1999). As CTS is a 
peripheral nerve lesion, sensory nerve conditions generally progress from numbness and tingling 
to a hot, burning sensation which is brought on by repetitive motion (Love, 2003). 
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A loss in the sensory nerve supply due to compression of the median nerve leads to CTS, 
where patients may complain of being clumsy and dropping items when using the affected hand 
(Love, 2003). Proprioception in the hand is affected by CTS and, as a result,  individuals who 
work with their hands lifting heavy objects or tools on a daily basis (e.g., mechanics, welders) 
will grip their tools or items in their hands harder than they need to as they cannot tell how hard 
they are gripping (Love, 2003). As the disease progresses, the motor supply of the nerve is 
affected, where patients may report general weakness between the thumb and the fingers. Love 
(2003) states that as the motor supply of the median nerve is affected, grip strength decreases 
further, as does the pinch strength between the tip of the thumb and the fingers. When motor 
control of the hand is affected, the patient can be classified as being in an advanced stage of the 
disease (Love, 2003). 
 
Although women are generally affected more than men after the age of 40, the incidence 
rate between the two sexes is nearly equal before the age of 40 years (Love, 2003). Females are 
more affected with CTS than males at a staggering rate of four to one after the age of 40, which 
may be mainly due to the smaller wrist size of females (Love, 2003). The carpal tunnel space of 
females is smaller than that of males but has the same number/size of tendons and nerves passing 
through it, leading to an increased chance for aggravation to occur (Love, 2003).After the age of 
40, with hormonal changes in a woman’s body, fluid retention and general swelling can lead to 
an increased incidence of CTS in women (Simon & Zieve, 2013). In the past, wome n filled the 
majority of clerical positions such as secretaries, clerks, accountants, and bank tellers. These 
mainly hand-wrist dominant careers were a strong contributor to the development of CTS in the 
female population (Love, 2003). 
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Overuse of the wrist. Thurston (2000) proposed that all individuals are predisposed to 
suffering CTS in their lifetime. CTS may develop when predisposition worsens because of 
lifestyle, health, and career influences. Most commonly, CTS is classified as an overuse injury, 
which may be caused by poorly designed job tasks, work stations, and practices (Carragee & 
Hentz, 1988; Weirich & Gelberman, 1993). Generally speaking, the more repetitive and 
strenuous a job or functional task is on the wrists, the more likely the individual is to suffer from 
CTS in the future. 
 
Not only is CTS brought on by work-related activities and repetitive motions, but it can 
also be brought on by a number of sport-specific movements. Sports such as cycling, football, 
golf, hockey, lacrosse, rock climbing, weightlifting, wheelchair sports, and wrestling may lead to 
an increased risk for CTS (McKeon, 2008). It is apparent that individuals need to be cautio us 
with their movements both at work and during their recreational time, constantly monitoring 
wrist position if discomfort arises. 
 
 
Distinctly, CTS arises from compression of the median nerve as it passes through the 
carpal tunnel (Love, 2003). As the carpal tunnel is a very confined area to begin with, it does not 
take much soft tissue swelling or fluid build up to cause a great deal of discomfort and pain to 
those individuals affected with CTS. Tissue damage in the carpal tunnel area that leads to CTS 
can be brought on by repetitive, forceful movements with the wrist held in a fixed position for 
extended periods of time (Dobyns, 1991). It does not matter if the wrist is held in neutral, flexed, 
or extended. As long as the wrist is held in a fixed position continuously, the risk of CTS is 
higher. Other specific causes of overuse damage in the carpal tunnel area stem from repetitive or 
prolonged tool use that causes the hand and wrist to vibrate (Dobyns, 1991). The types of tools 
that may aggravate the median nerve include jack-hammers, hammer drills, concrete saws, and 
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impact wrenches. If tools are used on a regular basis and not ergonomically designed, there is a 
greater risk for the development of CTS. Finally, damage to the structures in the carpal tunnel 
area can result from excessive data entry, mouse, computer keyboard and cash register use 
(Feuerstein, 1997). 
 
Although CTS is mainly an overuse injury where the onset of symptoms cannot be 
attributed to a single event, in some cases, it may be brought on by repetitive use combined with 
episodes of tissue damage to the carpal tunnel caused by injuries sustained during a fall onto an 
outstretched hand (Dobyns, 1991). CTS can be either unilateral where it affects only one wrist, 
or bilateral affecting both wrists. It is well documented that if the condition is unilateral, it often 
appears in the dominant wrist; while if the condition is bilateral, the symptom severity is greatest 
in the dominant wrist (Love, 2003). 
 
Manktelow, Binhammer, Tomat, Bril, and Szalai (2004) found that 50% of the reported 
CTS cases in the province of Ontario in 1996 (n=964) originated from fabrication or assembly 
line workers. Clerical workers accounted for 16% of the diagnosed population, with up to 75% 
of all cases reported having bilateral involvement. Manktelow et al. (2004) also reported that in 
some cases, patients experienced symptoms for as long as three years before receiving treatment, 
with as much as 46% of patients reporting ongoing symptoms even after receiving treatment. 
With so many cases reported, and with such a high rate of recurrence, there is an increasing need 
for better diagnostic tools and methods. 
Effect of Carpal Tunnel Syndrome on Society 
 
 
Healthcare. According to Fnais, Gomes, Mahoney, Alissa, and Mamdani (2014), there 
are approximately 10 procedures per 10,000 population carpal tunnel release surgeries performed 
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annually in Ontario. The performance of this many surgeries for one specific disease stresses the 
healthcare system, and reduces the amount of available surgery time that could be used to treat 
more severe diseases. Not only is the total number of surgeries carried out by the surgeons 
costly, but the expenses of postoperative care and rehabilitation also tax the healthcare system. 
 
 
Work force. The reported incidence of work-related musculoskeletal disorders, including 
CTS, has remained stationary since 1992, in contrast to other work-related injuries and illnesses 
that reached a peak in 1992 and have been on a steady decline since then (Falkiner, 2002). 
Falkiner (2002) points out that in 1999, CTS claims made up 1.6% of workplace injuries 
requiring time off work. With the number of reported CTS claims staying stable and not 
decreasing like other workplace injuries for so long, there is an increasing demand on all 
employers to keep updating their workplaces. Workplace updates could include work station 
renovations and tool replacement to make job tasks more ergonomically friendly for their 
employees. If the total number of reported cases is not being reduced, t here is still an issue with 
workplace practices, activities, and tools. 
 
CTS also puts stress on members of the workforce by increasing the total number of sick 
days taken per year. On average, the total number of days taken off for a medical condition is 
highest for those suffering from CTS (27 days) as compared to fractures (20 days) and 
amputations (18 days) (Falkiner, 2002). Lost time injuries cost employers significantly in the 
form of lost productivity in their workforce and delays in progress on certain projects and tasks. 
As time taken off work also results in workers filing compensation claims, employers are 
penalized and financial resources are stretched thin very quickly. 
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Individual life. Living with a medical condition or disease (e.g., CTS) stresses both an 
individual’s psychological and financial stability due to the cost of special medications and 
physical rehabilitation time. The overall cost of living with a long-term disability can add up 
very quickly, even in a society such as Canada where the medical system is supported very 
heavily by provincial funding. The stresses are more pronounced in countries without subsidized 
healthcare. For example, in the United States between the years of 1996-1997, a carpal tunnel 
claim cost an average of $13,263, while a claim in British Columbia in 1997 cost $11, 993 (Li, 
Liu, Miyazaki, & Warren, 1999). This was only surpassed by the cost of motor vehicle accidents, 
other traumatic injuries, and bone fracture, crush, and dislocation injuries (Falkiner, 2002). 
 
Diagnostic Techniques 
 
 
As CTS is becoming a prevalent condition, more websites, educational pamphlets, and 
information flyers are being produced and released discussing the condition, treatment, and 
prevention. The availability of information about CTS has led to more self-diagnoses being made 
by the general public before they receive an assessment from a medical professional. As the 
disease is more common in some workplaces, some employees self-diagnose themselves before 
being medically examined, frequently through the use of information on the internet (Falkiner, 
2002). 
 
 
The most common tests used in the diagnosis of CTS include the CCT, Phalen’s Test and 
Tinel’s Test, all of which attempt to reproduce the patient’s symptoms in order to confirm the 
diagnosis. All three tests are provocative in nature, and they may give false negative findings if 
the patient has excessive median nerve dysfunction, or the disease is in the later stages (Falkiner, 
2002). 
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The issue that arises with diagnosis of CTS is that there is not one specific test that is 
used. Medical professionals all have their own preferred method for testing and diagnosing CTS, 
which creates issues when other professionals are involved in the care of the patient. How does 
the CTS diagnosis by one professional compare to the diagnosis of another? Can a professional 
say that the chosen testing methodology for diagnosing CTS compares to the diagnostic 
technique that another professional uses? As Falkiner (2002) states, there is no standardized 
diagnostic technique for CTS. None of the physical tests, questionnaires, or electrodiagnostic 
techniques is, by itself, a “gold standard” for diagnosing CTS. 
 
Treatment Methods for Carpal Tunnel Syndrome 
 
 
Many treatment methods exist for CTS and include: manual therapy techniques (soft 
tissue mobilization, stretching, augmented soft tissue mobilization, neurodynamic technique), 
topical pain relief creams, splints and braces, electrotherapeutic modalities (ultrasound, 
transcutaneous electrical nerve stimulation), steroid injections, and surgical release methods 
(Jackson, 2012). While treatment methods have pros and cons, medical professionals have their 
personal preferences with regards to treatment methods; some professionals prefer to treat 
patients manually, and others prefer to treat using electrotherapeutic modalities. 
 
Optimally, the least invasive treatment methods should be utilized and exhausted first. As 
Love (2003) stated, the most essential care is through the early detection of early symptoms, but 
before a patient seeks surgery as a treatment option, he/she should seek advice from a 
professional specializing in upper quadrant, wrist, and hand dysfunction. Surgery has specific 
applications; for example, the aim of decompression surgery may be to increase the volume of 
the carpal tunnel space in order to relieve pressure on the median nerve (Love, 2003). Although 
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decompression surgery is a fairly quick and simple technique, Love (2003) points out that there 
are many complications that can arise such as hemorrhage, damage to the ulnar nerve, swelling, 
infection, weakness of finger flexion, and post-operative chronic pain and numbness 
 
Validity of an Assessment Tool 
 
 
In order to implement less expensive CTS treatment methods, health professionals and 
employers must use CTS assessment tool measures that are simple to use, but with high degree 
of validated evidence. One commonly accepted definition of validity used to provide evidence 
for the validation of assessment tool measures is “the degree to which evidence and theory 
support the interpretation of test scores entailed by proposed uses of tests” (Standards, 1999, p. 9). 
Kane (2006) also commented on the meaning of the relationship between validation and validity: 
“validation” and to a lesser extent the term “validity” tend to have two distinct but 
closely related usages in discussions of measurement. In the first usage, 
“validation” involves the development of evidence to support the proposed 
interpretations and uses; in this usage, “to validate an interpretation or use” is to 
show that it is justified. In the second usage, “validation” is associated with an 
evaluation of the extent to which the proposed interpretations and uses are 
plausible and appropriate. In this sense, “to validate an interpretation or use” is to 
evaluate its overall plausibility. The first usage implies an advocacy role, in the 
building of a case for the validity of a proposed interpretation. The second usage 
implies a more-or-less objective appraisal of the evidence, pro and con. (p. 17) 
To simplify this explanation, validity refers to the accuracy of the interpretation of scores from 
any test, which is the most critical aspect of any measure. 
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Evidence for validation of an assessment tool. In a number of ways, researchers have 
developed validity arguments to address the inferences made based on test-score interpretations 
when using an assessment tool (Kane, 2006). Validity arguments may entail providing evidence 
to support the test score interpretations and their relevance to the proposed use. These validity 
arguments may include construct-related evidence, content-related evidence, and concurrent- 
related evidence. 
 
Construct-related evidence. Standards (1985) defines construct-related evidence of 
validity as a category that focuses primarily on the test score as a measure of the characteristic of 
interest (p. 9). For example, endurance is a frequently used construct to measure athletes’ 
performance. Construct-related evidence of validity for the interpretations of test scores when 
measuring a construct can be obtained from a variety of methods. These methods may entail 
inter-correlations among items that can be used to support the assertion that a test measures 
primarily a single construct. The relationship to other variables is also another method that can 
be used to address the degree to which the construct being measured consistently relates to 
external variables (Standards, 1985). That is, when administering a test to measure pain, the 
researcher or practitioner may be interested in examining if pain increases or manifests in 
relation to time. This relationship may lead to a convergence of indicators that can be used to 
provide evidence for the validity of test score interpretations from the assessment tool. 
 
Content-related evidence. Standards (1985) states that content-related evidence of validity is 
 
 
the degree to which the sample of items, tasks, or questions on a test are representative of 
some defined universe or domain of content. The methods often rely on expert judgments 
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to assess the relationship between parts of the test and the defined universe, but certain 
logical and empirical procedures can also be used. (p. 10) 
 
For example, when developing an assessment tool to measure a specific construct (e.g., 
pain), the major facets of the construct to be measured can be identified and an expert in the area 
(e.g., physiotherapist, doctor) can be asked to assess the degree of pain manifested by a subject to 
each of those facets on the test. 
 
Face-related evidence. Holden (2010) defines face validity as “the appropriateness, 
sensibility, or relevance of the test and its items as they appear to the persons answering the test” 
(p. 637). For example, a doctor could have a patient complete a set of wrist exercises. After the 
patient had completed the exercises, the doctor would then ask the patient if they had any 
difficulty with certain exercises. 
 
Concurrent-related evidence. Standards (1985) states that concurrent-related evidence of 
validity is “the degree to which the criterion information obtained from a sample of items, tasks, 
or questions on a test relates to the same criterion information obtained from a standard when 
both measures are obtained simultaneously” (p. 10). For example, a researcher can correlate the 
measures obtained from a wrist pressure device created to assess pain with a standard 
compression test designed to measure pain by applying pressure to the wrist. If both measures 
correlate closely, then the measures obtained from the wrist pressure device have concurrent - 
related evidence of validity when assessing pain. 
 
Reliability of an Assessment Tool 
 
 
While validity is concerned with providing evidence for validation based on the 
inferences made from the assessment results of the tool or device, reliability is concerned solely 
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with how test scores are expected to vary when repeatedly using the assessment tool (Haertel, 
 
2006). The proportion of variance across replications of the measures obtained from the 
assessment tool is usually examined using reliability coefficients (Kane, 2006). That is, evidence 
of reliability can be provided by examining the internal consistency of the items on the 
assessment tool in relation to a latent variable or construct (e.g., pain). The strength of the 
relationship among the test-items can then be used as an indicator of how much variance is 
accounted for by the relationship of the items when measuring a latent variable or construct 
(Bonett, 2003). When measuring a construct using an assessment tool, implementing a pre- and 
post-test design can also test its reliability. The strength of the relationship between the pre and 
post-test measures can be used as an indicator of the variance present when repeating the 
measure (Bonett, 2003). Ideally, reliability and validity are established through the completion of 
any research study. Kane (2006) stated that the inferences made from test scores cannot be 
claimed as evidence of validity if the test scores are not proven to be reliable. 
Differences Between Self-Report and Direct Measures 
 
 
When providing evidence for the validation of test score interpretations, a researcher may 
use self-report questionnaires (subjective measures) or direct measures (objective measures). The 
self-report measures may include information related to “the primary complaint, mechanism of 
injury, characteristics of the symptoms, and related medical history” (Anderson, Hall, & Martin, 
2005, p. 96). Self-report information is mainly obtained by using a questionnaire that the 
individual fills out independently, addressing topics such as physical pain and difficulties with 
activities of daily living (ADLs). Direct measures, on the other hand, incorporate “measurable 
documentation relative to the affected individual’s condition” (Anderson et al., 2005, p. 96). 
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These measures may include assessment techniques examining functional abilities, range of 
motion, nerve conduction, physical strength, and sensation of the affected individual. 
 
Advantages and disadvantages of self-report questionnaires. Self-report questionnaires, more 
commonly known as subjective measures or outcome measures, have strengths and weaknesses. 
An advantage of self-report measures is that they “can effectively capture changes in both the 
explicit and the implicit components of the variable being measured, and, therefore, they can be 
better suited for the study of broadly defined concepts than objective measures” (Jahedi & 
Mendez, 2012, p. 3). Furthermore, self-report measures can provide a better method of 
examining latent constructs such as the patient’s attitude or satisfaction with a medical 
assessment or treatment. Lastly, they are easy to use clinically, with a diverse variety of 
instruments that are patient/injury specific and validated. 
The disadvantages of self-report measures vary. For example, Jahedi and Mendez (2012) 
reported two clear disadvantages. First, interpreting self-report measures can be more difficult 
than interpreting direct measures because they are expressed in ordinal scales. For example, 
individual understandings of the same question will vary based on interpretation. That is, if the 
responses to a self-report item are based on an ordinal scale (e.g., fair, good, very good) and two 
individuals answer the same question but one answers “fair” while another individual answers 
“good”, how can a researcher be sure that these two individuals are accurately answering the 
proposed question? Another disadvantage of self-report measures is that the questionnaire 
responses supply a subjective source of bias which can be either intentional or unconscious in 
nature (Vogt, Selvin, Widdowson, & Hulley, 1977). As self-report measures are most commonly 
questionnaires that are filled out individually by the patient, the patient can easily state that 
his/her current health or medical condition is better than it truly is. When assessing CTS for 
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example, it is easy for an individual to misread or improperly answer questions on a 
questionnaire. As questionnaires rely on individual response, an individual may choose to answer 
questions dishonestly to take advantage of the healthcare system, subsequently increasing the 
number of malingerers (Pransky, Feuerstein, Himmelstein, Katz, & Vickers-Lahti, 1997). The 
American Psychiatric Association (2000) defines malingering as the intentional reproduction of 
false or largely exaggerated complaints with the aim of receiving an incentive. This reward could 
include time off work, an insurance settlement, or drugs to treat a medical condition. Pransky et 
al. (1997) point out that through assessing diagnostic techniques, malingerers cannot be 
accurately identified through the use of subjective measures. The total number of malingerers is 
not known, however it is estimated that true symptom fraud occurs in less than 5% of all clinical 
CTS cases (Millender & Conlon, 1996). In order to reduce the number of malingerers within the 
healthcare system, there is a need to develop non-invasive objective testing protocols into one 
testing battery to increase the validity of CTS assessment and diagnosis. 
Advantages and disadvantages of direct measures. Direct measures, also known as 
objective measures, are “a basic measurement that can be based upon a standard unit preserved 
in some permanent location” (Michels, 1983, p. 210). Simply put, a direct measure can be 
represented by weight, height, or length of an object, for example. Direct measures provide an 
objective means of measuring the important physical and functional abilities during medical 
assessments and diagnoses to minimize the chance of inaccurate diagnosis and other errors that 
may occur with subjective measures.With respect to CTS, a direct measure can involve nerve 
conduction testing of the median nerve, or grip strength testing of an affected wrist. With respect 
to a cardiac patient, a direct measure would, for example, use a heart rate monitor to gauge an 
individual’s heart rate during a test. One advantage of direct measures is that they can provide an 
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unbiased or objective measure (Reuben & Siu, 1990). In a medical situation, for example, an 
individual may report that their CTS symptoms have progressively become worse over time. 
Another advantage of direct measures is that “this method may provide more accurate 
and reliable information than self report or proxy report” (Reuben & Siu, 1990, p. 1105). Unlike 
subjective measures, direct measures eliminate individual error. For example, an individual 
suffering from CTS may rate his/her overall physical symptoms on a questionnaire as being 
worse than these symptoms actually are. Objective measurement (e.g., nerve conduction tests) on 
the same individual, however, may indicate that the symptoms are not as severe as reported on 
the questionnaire. As objective scores are typically considered more representative measures of a 
condition than subjective scores, the treating medical professional may opt to use objective 
measures as an avenue to get a more accurate idea of the individual’s true co ndition and abilities. 
 
While direct measures have many advantages, these measures also have disadvantages. 
For example, Reuben and Siu (1990) reported that a disadvantage of direct measures is cost. 
Since they require more staff time and effort, clinical time must be booked with a professional. 
In addition, direct measures can be costly in terms of the labour and consultation to the 
individual receiving the testing as they may have to book time off work to have the testing 
completed. Lost time in the workplace costs not only the employee, but also the employer. 
Furthermore, Hadler (1990) and Mackinnon (2002) found that in CTS cases that are labeled as 
“cumulative trauma disorders,” the symptoms may not always be substantiated by the use of 
direct measures, as the CTS symptoms frequently persist even when negative findings on well- 
established assessment methods are found. 
 
There is a need to produce a testing battery that will assist in the better diagnosis of CTS 
 
as there are currently many subjective questionnaires and objective testing measures. The issue is 
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that there is no true correlation seen between any two testing protocols. For example, Pransky et 
al. (1997) reported that many of the current questionnaires used to assist with diagnosing CTS 
are generalized to the upper limb, and do not focus directly on the wrist. 
Assessing Carpal Tunnel Syndrome via Self-Report Questionnaires 
 
According to Sambandam et al. (2008), there are six main self-report questionnaires used 
in the assessment and diagnosis of CTS. These questionnaires include the Boston Carpal Tunnel 
Questionnaire (BCTQ), Michigan Hand Outcome Questionnaire (MHQ), Disability of Arm 
Shoulder and Hand (DASH), Patient Evaluation Measure (PEM), Historical-Objective Scale (Hi- 
Ob Scale), and the Upper Extremity Functional Scale (UEFS). 
Boston carpal tunnel questionnaire. The BCTQ, created by Levine et al. (1993), is the 
most commonly used outcome measure in the assessment of patients with CTS (Sambandam et 
al., 2008). The focus of the questionnaire is on two scales, the symptom severity scale (SSS, 11 
items) and functional status scale (FSS, eight items). 
The scales were found to be highly reproducible, showing intraclass reliability of r= .91 
for the SSS and an even higher r= .93 for the FSS. Cronbach’s alpha was found to be .89 for the 
SSS and .91 for the FSS (Sambandam et al., 2008). 
Michigan hand outcome questionnaire. The MHQ was developed by Chung, Pillsbury, 
Walters and Hayward in 1998 to assist with assessing various hand disorders. The test 
questionnaire items were grouped into six specific areas, including overall hand function, ADLs, 
pain, work performance, aesthetics, and patient satisfaction with hand function (Chung, 
Pillsbury, Walters, & Hayward, 1998). Unlike other questionnaires, the MHQ focuses on both 
unilateral and bilateral CTS, with four of the six areas relating to both the right and left hand; this 
allows for comparison of an affected wrist to an unaffected wrist (control) when possible. 
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Researchers reported that the test-retest reliability for the MHQ ranged from .81 on the 
aesthetics scale to .97 on the ADL scale. Test-retest reliability was tested by having participants 
fill out the initial questionnaire in a clinical setting and completing the same questionnaire one 
week later to reduce recall rate. Cronbach’s alpha, which tests internal consistency, was shown to 
be between .86 for the pain scale and .97 for the ADLs scale (Chung et al., 1998). During pilot 
studies, factor analysis was used to reduce the MHQ to six main factors: overall hand function, 
ADLs, pain, work performance, aesthetics, and patient satisfaction with hand function. A total of 
37 testing questionnaires are listed under the six main factors stated above (Sambandam et al., 
 
2008) and content validity was evaluated by hand surgeons, therapists, and patients with hand 
disabilities (Chung et al., 1998). Construct validity was established by comparing the items in the 
MHQ to an already validated similar questionnaire, the SF-12. The SF-12 is a general 
questionnaire that is used to assess a variety of upper limb conditions, focusing on difficulty in 
completing tasks and general physical and mental health (Ware, Kosinski, & Keller, 1996). 
Disability of arm, shoulder, and hand. The DASH is a general questionnaire, which 
was created in a joint effort by the American Academy of Orthopaedic Surgeons, the Council of 
Musculoskeletal Societies, and the Institute for Work and Health (Beaton et al., 2001, 
Sambandam et al., 2008). It assists with diagnosis and assessment of upper extremity issues from 
the shoulder to the hand. Although the DASH is the most widely used subjective measure for 
upper extremity disorders, this general questionnaire has not been extensively studied for its 
transferability to be used in assessing CTS specifically. 
The researchers established criterion validity for the questionnaire through demonstrating 
a strong correlation between the DASH and the PEM. Other than this original validity testing, 
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there has been no research done to provide further evidence of validity of the questionnaire in 
assessing and diagnosing CTS (Sambandam et al., 2008). 
Patient evaluation measure. The PEM is a self-administered measure of a patient’s 
physical health. The PEM has three subscales dealing with treatment (five items), feeling and 
using the hand (10 items), and overall assessment quality (three items). The questionnaire is 
vague and can be easily misunderstood by either the patient answering the questions or the 
treating medical professional interpreting the results. 
Overall reliability of the PEM was found to be .83, with inter-item consistency of .88 and 
internal consistency of .94 (Sambandam et al., 2008). Although initial testing results were 
positive, the first validity testing was not carried out for almost five years after the questionnaire 
was put into practice. The testing that was completed showed high correlation between grip 
strength testing and overall perceived level of distress items within the PEM questionnaire 
(Sambandam et al., 2008). 
Historical-objective. Created in 2002 by Giannini and colleagues, the Hi-Ob Scale is 
based on the clinical history and physical examination findings of physicians (Sambandam et al., 
2008). Although it was tested directly on individuals suffering from CTS, it has many 
disadvantages. Some disadvantages of the questionnaire are that it has never been validated by 
external sources, commonly missed or misunderstood questions have not been identified, time to 
completion has not been established, and cross-cultural validation is lacking (Sambandam et al., 
2008). 
 
In the original research testing, the questionnaire was validated using 168 hands that were 
affected by CTS. Evidence of validity was provided by showing a high correlation between the 
Hi-Ob questionnaire score and the symptom/functional subscales of the more popular BCTQ, as 
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well as neuro-physiological measures (pain) (Sambandam et al., 2008). As the two 
questionnaires test roughly the same aspects of CTS, the functional and symptomatic subscales 
of the Hi-Ob were validated against the already validated BCTQ function and symptom 
subscales. Researchers tested the reproducibility of the questionnaire reporting a Cohen 
coefficient of .69, and good overall responsiveness with the testing. 
Upper extremity functional scale. The UEFS was created by physicians and 
occupational therapists testing patients with upper extremity disorders (Sambandam et al., 2008). 
Developed in 1997 by Pransky, Feuerstein, Himmelstein, Katz, and Vickers-Lahti, this non- 
specific questionnaire of the upper extremity focuses on assessing the outcome of work-related 
upper extremity disorders. The questionnaire is not specific, and can be used on any part of the 
upper extremity from the shoulder region to the fingers. A serious drawback to this questionnaire 
is that it only takes into account functional disabilities of the patient and ignores symptom 
severity and objective scores of physical, mental, or social health (Sambandam et al., 2008). To 
score the questionnaire, a 10 item Likert scale is used, with a score of one representing no 
problem with a specific activity, and 10 representing not being able to perform the activity at all. 
Although this questionnaire was designed to assess functional disabilities of the upper extremity, 
it is also found to have an internal consistency range varying from an alpha score of .83 to .93 for 
patients with CTS (Sambandam et al., 2008). 
Construct related evidence of validity for the UEFS was established by demonstrating a 
high degree of correlation between the UEFS score and a Likert scale measure of subjective pain, 
physical measures, and psychological measures. 
Assessing Carpal Tunnel Syndrome via Direct Measures 
 
Carpal compression test. Durkan developed the CCT in 1991. The test consists of 
applying a steady pressure of 150mm Hg directly over the carpal tunnel space with the pads of 
26  
the thumb tips in order to compress the median nerve. This pressure is held steady for a 
maximum of 30 seconds, and the testing ceases when the participant’s CTS symptoms (pain 
and/or numbness) are aggravated or worsened. Durkan (1991) applied pressure to the median 
nerve in two ways: 1) with the assistance of a hollow ball attached to a blood pressure gauge to 
show the researcher how much pressure they were applying to the carpal tunnel space and; 2) 
with just the thumb pads over the carpal tunnel space applying what the researcher believed to be 
150mm Hg pressure. The problem that arises with the second method is that the individual 
applying the pressure to the carpal tunnel space has no true knowledge of how much pressure 
they are applying to the carpal tunnel space. 
 
A total of 31 participants were assessed in this study, with a total of 46 wrists being 
 
tested. The CCT was found to be more sensitive and specific than the Tinel’s  and Phalen’s Tests 
when tested on the participants with CTS, producing positive results in 87% of the hands 
assessed (69% positive with Phalen’s, 56% with Tinel’s) (Durkan, 1991). 
 
 
Electrodiagnostic testing. Electrodiagnosis is an extension of the history and physical 
examination of CTS, which began in the 1950’s (Wang, 2013). There are currently two forms of 
electrodiagnostic testing being used: electromyography (EMG) and nerve conduction study 
(NCS). Of the two, NCS is more valuable than EMG testing due to the demyelination involved in 
CTS (Wang, 2013), with NCS better assessing the demyelination of the nerve tissue in 
comparison to EMG. Since electrodiagnostic techniques need to be administered under strict 
conditions to gain the best insight into the patient’s condition, variables such as electrode 
placement, distance measurements, stimulation intensity, and skin temperature must be closely 
monitored for the most reliable results (Wang, 2013). One method used to assess CTS symptoms 
electrodiagnostically is through the use of the combined sensory index (CSI). The CSI is an 
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attempt to maximize the sensitivity of diagnosis without reducing specificity (Wang, 2013). The 
CSI is calculated through the combination of three sensory latencies, where CSI= 
ringdiff+thumbdiff+palmdiff (Wang, 2013). When the upper latency limit is set to 0.9s, the test 
sensitivity is 0.83, while specificity is 0.95 (Wang, 2013). 
 
Although this testing method produces reliable results, the procedure is typically 
expensive; for example, Fowler, Maltenfort, and Ilyas (2013) reported that the average cost of an 
electrodiagnostic procedure ranged between $400.30 to $428.30 at general practitioner clinics 
and specialists’ clinics, respectively. With the availability of CTS self-report and direct measures 
that are either costly or lack evidence of validity, developing assessment tools that are simple and 
less expensive to administer in CTS diagnostics would assist patients and reduce healthcare 
costs. 
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CHAPTER THREE- METHOD 
 
Goals of the Study 
 
 
The purpose of this study was to develop a prototype for a CTCAT and provide evidence 
of validity and reliability for the use of the CTCAT in assessing CTS when compared to the 
BCTQ and a 10 point self-report Likert pain scale. 
 
Prototype Development Procedures 
 
 
For more information on the CTCAT, see Appendix A: Carpal Tunnel Compression 
Assessment Tool. The proprietary CTCAT as depicted in Figure 2 and Figure 3 is a portable 
testing device that is easy to set up and use. The device is a small box that has one opening for 
the hand of the participant. There is a hinged moving arm that is locked in place with a Velcro 
strap once the participant’s hand is in the proper testing position. The carpal tunnel space is 
rested on top of a pressure ball that pushes directly into the carpal tunnel space, while the palm 
rests on a ball rest during the testing session. On the bottom of the device, there is an inflatable 
bladder that presses on a pressure ball, which pushes on the carpal tunnel region of the wrist. The 
bladder is inflated by a hand pump, which the researcher controls. To monitor the pressure of the 
bladder, a small pressure gauge is attached. The pressure ball serves to compress the median 
nerve in the same fashion as the medical professional would by applying a steady pressure with 
his/her thumbs to conduct the CCT. 
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Figure 2. CTCAT device. The device in the open position, with the blue inflation pad, the white 
hand rest ball, and the black pressure ball. 
 
 
 
 
Figure 3. CTCAT testing position. The carpal tunnel space is placed on top of the black pressure 
ball with the retainer strap on the back of the wrist. The hand rests on the white ball to maintain 
wrist angle during testing. 
 
Device development took place over the period of five months, where design ideas were 
brought forward and prototypes were created. During creation of the device, it was kept in mind 
that the CTCAT needed to apply pressure steadily and evenly for the allotted testing time. In 
order to apply pressure to the wrist at the specified pressure, there needed to be a pressure gauge 
incorporated into the device to allow the testing researcher to monitor the pressure during the 
testing. This was accomplished through attaching a sphygmomanometer gauge to the device. The 
device also had to have a quick-release feature to allow pressure to be removed from the 
participant’s wrist the second their CTS symptoms increased. The quick-release function was 
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then added to the device with the Velcro strap on the end of the moving arm. This would then 
allow the participant to open the device immediately upon feeling a change in their CTS pain or 
symptoms. Wood was chosen as the primary construction material for this prototype due to its 
low cost and ease of use. Future prototypes will be constructed of aluminum and other light 
weight materials to save on weight and also increase durability of the device. Mr. Dan Vasiliu 
assisted with device development and construction, putting his engineering knowledge in the 
area to use. Lastly, clinical guidance was provided by an orthopaedic surgeon and an 
occupational therapist to use the CCT (Durkan, 1991) as the physical testing protocol for the 
study. 
 
As was found in the pilot study, the original pressure ball spread the required pressure 
over too large of an area when the device was inflated, which then required modifications to be 
made to the device. The first pressure ball that was used was an inflation bulb from a 
sphygmomanometer, which is soft rubber. As the pressure placed on the ball increased, the 
pressure point applied to the wrist got larger, which spread the load over a larger area. This 
pressure area did not mimic the pressure area of the average thumb very well (roughly one inch 
squared). The sphygmomanometer bulb was then replaced with a smaller, harder ball, and this 
ball held its shape better when the pressure load was placed on it, mimicking the area of the 
thumbs much closer than the previous ball. The flaw was noted after the first round of testing 
was completed and there were no positive results being produced with the CTCAT. The ethics 
package was then sent to Health Canada for the proprietary device to be reviewed and approved 
for use. Upon review, Health Canada granted approval for the device to be used as a Class 1 
medical device for research purposes. After developing a prototype that appeared to satisfy the 
design requirements of providing a portable instrument that allows an objective measurement of 
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pressure that mimics a clinician’s thumb pressure, the next step was to address issues of validity 
and reliability which led to the following research questions. 
 
Research Questions 
 
 
The following research questions guided the study: 
 
1.   How reliable are the measures obtained from the BCTQ with the current data? 
 
2.   Can a 10 point self-report Likert pain scale question be used to assess CTS when 
compared to the BCTQ? 
3.   To what extent is the CTCAT able to assess CTS when compared to the BCTQ and 10 
point self-report Likert pain scale? 
 
In order to address the purpose of the study and answer these research questions, 
 
evidence of reliability and validity of the BCTQ, CTCAT and the 10 point self-report Likert pain 
scale were provided by using quantitative and qualitative methods. The data included self-report 
measures of pain and direct measures of response time based on participants’ tolerance to 
withstand pain due to carpal tunnel compression. 
 
Participants 
 
 
Recruitment. Carpal tunnel syndrome participants were recruited for this study through 
convenience sampling by using posters (see Appendix D: Recruitment Poster), asking 
individuals to participate, and contacting medical clinics within the city of Thunder Bay from 
November 2013 to February 2014.  This process was conducted over three months. All potential 
participants must have been over the age of 18 at the time of testing to be included. In the case of 
medical clinics, recruitment packages were submitted multiple times to 10 large clinics (e.g., 
physiotherapy, chiropractic, medical doctor) in Thunder Bay to ensure t he most representative 
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sample size possible. Before distributing the recruitment packages to the medical clinics, 
however, the practicing professionals were asked about their willingness to help recruit 
participants for the study. If the professional expressed that he/she was currently treating patients 
with CTS and willing to assist with recruiting participants, recruitment packages were left at the 
clinic to be distributed to the potential participants. Ten participants with CTS were recruited to 
this study through the use of these recruitment procedures. Carpal tunnel syndrome participants 
who had decompression surgery were less difficult to recruit as these participants were being 
treated by medical professionals and clinics for post-surgery rehabilitation. Out of the 10 
participants with CTS, six had decompression surgery, and four did not have decompression 
surgery. All of the participants with CTS had the condition bilaterally. 
 
Nine control participants were recruited directly by the researchers. Classmates, family 
and friends were asked to partake in the study. These participants were then asked to refer 
another individual to the study. Potential control participants were included if they had no wrist 
pain or discomfort, and were excluded if they had sought medical attention for a hand or wrist 
condition in the past. 
 
There was an attempt made to both gender match and age match participants in the 
control group to the CTS group. The age of participants included in this study ranged from 20 to 
67 years old. The CTS group included six female participants and four male participants, while 
the control group was composed of six female participants and three male participants. The 
average age of the CTS group was 46 years old, while the average age of the control group was 
34 years old. 
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Exclusion. Potential participants for the CTS testing group were excluded if his/her CTS 
symptoms and pain were not clinically diagnosed by a medical professional as truly being CTS. 
These individuals were excluded from the study to ensure that the testing was only completed on 
participants with CTS and not other hand and wrist ailments. Potential participants for the 
control group were excluded if they reported any hand and/or wrist difficulties such as 
numbness, soreness, or stiffness in the hand and wrist area. 
 
Testing. Participant testing took place in the School of Kinesiology research laboratory at 
Lakehead University, Thunder Bay, Ontario. Participant testing sessions took place after work 
hours to ensure that participants were able to attend his/her testing sessions on the scheduled 
days. The testing period lasted a total of one month. Participant testing was approved by 
Lakehead University’s Research Ethics Board before testing commenced. Written informed 
consent was obtained from all participants in the study (see Appendix H: Control Participant 
Consent Form and Appendix I: Carpal Tunnel Syndrome Participant Consent Form). 
 
Instruments 
 
 
Boston carpal tunnel questionnaire. (See Appendix B: Boston Carpal Tunnel 
Questionnaire). This instrument was used to address the first research question of this study. The 
BCTQ is a two subscale questionnaire, comprised of a symptom severity scale (SSS, pain, 
discomfort) and a functional status scale (FSS, difficulty with certain daily activities). 
 
The BCTQ questionnaire asks straight forward questions, and pertains directly to the area 
of interest in this study (the wrist and hand). The BCTQ is easy and quick to fill out, and gives 
accurate scores as to the difficulty and pain associated with the participants’ CTS symptoms. The 
BCTQ was chosen as part of the subjective testing aspect for the study due to its simplistic 
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nature and focus specifically on CTS. Few hand and wrist medical questionnaires in existence 
are as specific as the BCTQ in addressing issues specifically dealing with the hand and wrist. 
 
Ten point self-report Likert scale. (See Appendix G: 10 Point Likert Pain Scale). This 
instrument was created by the researcher to provide additional information on participant level of 
pain before and after each testing session. Participants were asked to rate their perceived level of 
pain when asked the following question: “Perceived level of pain: please rate your pre-/post-test 
pain and/or discomfort in your wrists”. The measures of pain obtained from the 10 point self- 
report Likert scale were compared to the BCTQ to provide concurrent-related evidence of 
validity for the 10 point Likert scale as a measure of pain. “Perceived level of pain: please rate 
your pre-/post-test pain and/or discomfort in your wrists”. The pain scale was rated on a scale of 
one to 10, one meaning no pain or limited pain in the wrist/hand area from CTS symptoms; 10 
meaning the worst pain the participant felt in relation to his/her CTS symptoms. 
 
Carpal tunnel compression assessment tool. (See Appendix A: Carpal Tunnel 
Compression Assessment Tool). This instrument was created by the researchers to mimic the 
CCT created by Durkan (1991). The device aims to remove the subjective judgment of medical 
professionals to minimize measurement error that can occur when the CCT is completed 
manually due to differences in thumb pad size and the medical professionals’ kinesthetic feeling 
of exerted pressure. 
 
Procedures for Assessing Reliability and Validity 
 
 
Participants were administered two physical testing sessions two days apart, with each 
testing session containing a pre- and post-test to answer the research questions pertaining to this 
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study. Both testing sessions that were carried out used the exact same testing procedures as one 
another, being the BCTQ, the 10 point Likert pain scale, and the CTCAT. 
 
Each participant (control group and CTS group) was asked to complete the consent form 
upon arriving on their first day of testing. Once the consent form was completed, the participant 
was then asked to complete the BCTQ in regards to their CTS symptoms/discomfort over the 
previous 24 hour period. All participants were asked to complete the BCTQ as honestly as 
possible to avoid skewed testing results. For testing session two, the participants were given the 
BCTQ to complete upon arriving for testing. Although the BCTQ has strong evidence of 
reliability and validity as stated by Sambandam et al. (2008), further evidence of reliability are 
provided with the current data to verify the consistency of the measures obtained from the BCTQ 
across replications with the current data.The participants (both CTS and non-CTS) were then 
asked to rate his/her CTS pre-test pain via the 10 point Likert scale before conducting the 
CTCAT on both testing dates. 
 
 
The participants were asked to remain seated after completing the required pre-test forms 
(consent form, BCTQ, 10 point Likert pain scale) and to insert his/her dominant hand into the 
CTCAT device with the carpal tunnel area being placed directly over the centre of the pressure 
ball. Once the wrist had been rested on the pressure ball in the proper position by the researcher, 
the wrist angle was adjusted through the use of an adjustable ball rest. The pressure bladder was 
then inflated to 150mmHg as per the CCT guidelines created by Durkan (1991). Pressure was 
maintained at 150mmHg for a maximum of 30 seconds based on testing protocol guidelines 
stated by Durkan (1991). Participants were reminded that if their CTS symptoms worsened 
during testing that the testing would be stopped immediately by releasing the Velcro safety strap, 
which instantly released the pressure applied on the carpal tunnel area. 
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After completing the CTCAT test, participants were asked again to rate his/her level of 
pain/discomfort using the 10 point Likert scale as a post-test pain measure. Lastly, before 
participants left the testing session, a second testing session was booked for two days from their 
first testing session. 
 
Analysis- Research Question One- How reliable are the measures obtained from the 
 
BCTQ with the current data? 
 
 
Cronbach’s alpha inter-item reliability tests for the BCTQ were conducted to verify the 
internal consistency of the questionnaire items as measures of pain when diagnosing individuals 
with CTS using the current data. Intraclass correlations were also computed to verify the 
consistency across replications of the BCTQ with the current data by comparing the BCTQ 
scores of session one and two. As the non-CTS participants’ questionnaire responses showed no 
variability, the statistical results for this group data set were excluded. Intraclass correlation 
coefficients were computed by comparing the data of session one and two to provide evidence of 
consistency across replications when administering the BCTQ. 
 
A test of normality was completed to further support the results provided by the BCTQ. 
The test of normality ensured that the results fell within the normal distribution curve when 
assessing scores from both part one and part two of the questionnaire. 
 
Analysis- Research Question Two: Can a 10 point self-report Likert pain scale 
question be used to assess CTS when compared to the BCTQ? Evidence of reliability is 
provided by conducting two intraclass correlation analyses to compute correlation coefficients. 
The first intraclass correlation analysis was conducted by comparing the 10 point Likert scale 
pre-test pain measures between session one and two. The second intraclass correlation analysis 
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was conducted by comparing the 10 point Likert scale post-test pain measures between session 
one and two. 
 
Concurrent-related evidence of validity for the 10 point Likert pain scale was provided by 
computing an intraclass correlation between the pre-test Likert pain scale scores and the BCTQ 
part one. Before any statistical analyses were completed, the scores of the BCTQ part one and 
the 10 point Likert pain scale had to be scaled as the BCTQ part one is scored out of 45, and the 
 
10 point Likert scale is scored out of 10. Once the scores for two instruments were scaled by 
computing z-scores, the statistical analyses were completed. As there was no noted change in 
pain for the non-CTS participants, this group was excluded from this part of the statistical 
analysis. 
 
Construct-related evidence was provided by comparing the 10 point Likert scale pre-test 
pain measures to the BCTQ part two, which measures difficulty with certain ADLs when 
affected by CTS using intraclass correlation analysis. As there was no noted change in pain for 
the non-CTS participants, this group was excluded from this part of the statistical analysis. 
 
Face-related evidence of validity was obtained from qualitative measures by asking the 
participants the following open ended question: “At any time after the testing session, did your 
CTS symptoms increase? If so, please describe the symptoms and duration of aggravation” to 
triangulate the measures. This rationale is also supported on the standards on evidence for 
validation “based on participants’ qualitative responses” (Patton, 2002). To support the 
qualitative measures, descriptive and inferential statistics analyses were conducted. 
 
A test of normality was completed to further support the results provided by the 10 point 
 
Likert pain scale as the scale rates participant pain and discomfort on a scale of one to 10. The 
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test of normality ensured that the results provided from the pre-test and post-test fell within the 
normal distribution curve. 
 
Analysis- Research Question Three: To what extent is the CTCAT able to assess 
CTS when compared to the BCTQ and 10 point self-report Likert pain scale? Evidence of 
reliability for the CTCAT was established through using the test-retest method. Times measured 
between sessions one and two were compared to examine the degree to which the time measures 
produced by the CTCAT were consistent across replications. 
 
To provide convergent-related evidence of validity, the CTCAT time scores were 
correlated to the pain measured during the test. Pain measured during the test was computed by 
subtracting the 10 point Likert scale pre-test pain measures from the post-test pain measures. 
 
To provide discriminant-related evidence of validity, the CTCAT time to symptom onset 
measures were correlated to BCTQ part one and the 10 point Likert scale pre-test data. 
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CHAPTER FOUR- RESULTS 
 
To provide evidence of reliability and validity of the instrument measures used to 
validate the measures of the CTCAT, this chapter contains the results that answer the three 
research questions. Five months of CTCAT design and development work resulted in a prototype 
that could subsequently be assessed for reliability and validity. Three group data sets were 
assessed: non-CTS participants, CTS participants and all testing participants, which included 
non-CTS and CTS participants. The results are provided in terms of descriptive, inferential 
statistics, correlations, and qualitative measures. 
 
Research Question One- How reliable are the measures obtained from the BCTQ with the 
current data? 
 
Inter-item reliability tests for the BCTQ. As shown in Table 1, the Cronbach’s alpha 
 
coefficients for testing session one for part one of the BCTQ ranged from: r= .925, p< 0.001, n= 
 
10 (CTS participants) to r= .972, p< 0.001, n= 19 (all participants). Results for part two of the 
 
BCTQ for testing session one varied from: r= .968, p< 0.001, n= 10 (CTS participants) to r= 
 
.978, p< 0.001, n= 19 (all participants). 
 
 
The Cronbach’s inter-item reliability coefficients for testing session two, part one of the 
 
BCTQ as depicted in Table 2, ranged from: r= .922, p< 0.001, n= 10 (CTS participants) to r= 
 
.974, p< 0.001, n= 19 (all participants). Cronbach’s alpha inter-item reliability scores for part 
two of the BCTQ for testing session two varied from: r= .938, p< 0.001, n= 10 (CTS 
participants) to r= .963 p< 0.001, n= 19 (all participants). Reliability scores for testing session 
two, in terms of internal consistency of the items, were similar to those of testing ses sion one. 
This outcome indicated that the measures obtained from the BCTQ during testing session one 
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and two provided reliable measures in terms of internal consistency of the test items to assess a 
 
patient’s pain and difficulty with certain ADLs when affected by CTS. 
 
 
Table 1 
 
Inter-item Reliability for BCTQ Testing Session One 
 
Participants r n 
 
CTS, part 1 .925 10 
 
CTS, part 2 .968 10 
 
All, part 1 .972 19 
 
All, part 2 .978 19 
 
 
 
Note: p< 0.001 
 
Table 2 
 
Inter-item Reliability for BCTQ Testing Session Two 
 
Participants r n 
 
CTS, part 1 .922 10 
 
CTS, part 2 .938 10 
 
All, part 1 .974 19 
 
All, part 2 .963 19 
 
 
 
 
Note: p< 0.001 
 
Test/retest reliability measures of the BCTQ. Table 3 shows the results of these tests. 
The intraclass correlation scores for the BCTQ part one were as follows: r= .954, p< 0.001, n= 
10 (CTS participants) to r= .985, p< 0.001, n= 19 (all participants). Part one of the BCTQ 
addresses the participants’ pain and discomfort in relation to their CTS sympto ms over the 
previous 24 hour period. The outcome of these correlation scores suggested that the BCTQ part 
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one provided consistent measures of pain across replications of the test when using the current 
data. 
 
The intraclass correlation scores for the BCTQ part two, which measured difficulty with 
certain ADLs over the previous 24 hour period were also computed by comparing the data of 
session one and two. The intraclass correlation coefficients were as follows: r= .976, p< 0.001, 
n= 10 (CTS participants) to r= .987, p< 0.001, n= 19 (all participants). The outcome of the 
intraclass correlation coefficients for the CTS participants group indicated that the BCTQ part 
two provided reliable measures of the participant’s difficulty with certain ADLs when 
administering the test on more than one occasion. 
 
Table 3 
 
Intraclass Reliability for BCTQ   
 
Participants r n 
CTS, part 1 .954 10 
CTS, part 2 .976 10 
All, part 1 .985 19 
All, part 2 .987 19 
 
Note: p< 0.001 
 
Test of normality for the Boston carpal tunnel questionnaire. A Shapiro-Wilk’s test 
(p> .05) (Shapiro & Wilk, 1965; Razali & Wah, 2011) showed that the BCTQ scores were 
approximately normally distributed for both the symptom severity scale and the functional status 
scale for testing session one. For the symptom severity scale, skewness was found to be -0.038 
(SE = 0.717) while kurtosis was found to be 0.289 (SE = 1.40); a skewness of 0.242 (SE = 
0.717) and a kurtosis of 1.251 (SE = 1.40) was found for the functional status scale. 
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For testing session two, the symptom severity scale skewness was found to be -0.483 (SE 
 
= 0.687) while kurtosis was found to be 0.617 (SE = 1.334); a skewness of 0.394 (SE = 0.687) 
and a kurtosis of -0.951 (SE = 1.334) was found for the functional status scale. The outcome of 
the Shapiro-Wilk’s test confirmed that the data collected from the BCTQ symptom severity scale 
and the functional status scale fell within the normal distribution curve. 
 
Research Question Two- Can a 10 point self-report Likert pain scale question be used to 
assess CTS when compared to the BCTQ? 
 
Research question two related to assessing the participants’ perceived level of pain at the 
wrist before and after administering the CCT. This question was used as criteria to provide 
evidence for the validation of the CTCAT measures. Evidence of reliability and concurrent- 
related evidence of validity are provided to support research question two. 
 
Evidence of reliability. Table 4 shows the results of this test. 
 
 
Non-carpal tunnel syndrome participants. As no participants in the non-CTS group 
reported a change in pain between pre- to post-test pain during session one and two, there was 
not need to conduct an intraclass correlation analysis for this group. 
 
Carpal tunnel syndrome participants. The reliability scores for the 10 point Likert pain 
scale pre-testing pain measures between session one and two produced moderate reliability 
measures; r= .770 (p= .020, n= 10); while the post-testing pain reliability for this group data set 
was r= .772 (p= .019, n= 10) between session one and two. Significant moderate correlations 
suggested that the 10 point Likert scale scores showed consistency across replications when 
assessing the participants’ pain both before and after the physical testing. 
43  
All participants. The reliability scores for the 10 point Likert pain scale pre-testing pain 
measures between session one and two produced reliability scores of r= .867 (p< 0.001, n= 19). 
Post-testing pain reliability measures for this group data set was, r= .898 (p< 0.001, n= 19) 
between session one and two. Significant correlations suggested that the 10 point Likert scale 
scores were consistent across replications when assessing the participants’ pain before and after 
the CTCAT physical testing session. 
 
Table 4 
 
Pre-test and Post-test Pain Score Reliability   
 
Participants r p n 
CTS, pre .770 .020 10 
CTS, post .772 .019 10 
All, pre .867 < 0.001 19 
 
All, post 
 
.898 
 
< 0.001 
 
19 
 
Evidence of concurrent validity. Table 5 depicts these results. 
 
 
Non carpal tunnel syndrome participants. As there was no noted change in pain for the 
non-CTS participants when using either the BCTQ or 10 point Likert scale, this group was 
excluded from this part of the statistical analysis. Table 5 depicts these results. 
 
Carpal tunnel syndrome participants. The intraclass correlation result produced for 
testing session one when comparing the scores of the BCTQ part one to the 10 point Likert scale 
pre-test pain scores was  r= .885, p= .002, n= 10; while the intraclass correlation result for testing 
session two was  r= .871, p= .003, n= 10. Strong significant correlations for the CTS only 
participant group data set suggested that the BCTQ part one and the 10 point Likert scale pre-test 
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pain questionnaire measured pain to almost the same degree as one another. Since the BCTQ is 
considered a standard measure of pain in CTS diagnosis felt before the administration of the 
CTCAT test, this outcome provided concurrent-related evidence of validity for the use of the 10 
point Likert Scale as a measure of pain in CTS diagnosis. 
 
All participants. The correlation scores for testing session one when comparing the 
 
BCTQ pain scores to the 10 point Likert pre-test pain measures produced significant results of r= 
 
.897 p< 0.001 n= 19. Testing session two also produced significant correlation results of r= .906 
p< 0.001 n= 19. Since healthy participants were included in this part of the statistical analysis, it 
was expected that the correlation scores would be higher than the CTS only group. Significant 
results from this analysis, however, suggest that the 10 point Likert pain scale pre-test data and 
the BCTQ part one pain measures are strongly related. This outcome provided concurrent-related 
evidence of validity. 
 
Table 5 
 
Concurrent Validity for 10 Point Likert Scale Compared to BCTQ 
 
Participants r p n 
CTS, session one .885 .002 10 
CTS, session two .871 .003 10 
All, session one .897 < 0.001 19 
All, session two .906 < 0.001 19 
 
Evidence of construct validity. Table 6 illustrates these results. 
 
 
Carpal tunnel syndrome participants. Pearson’s correlation for the 10 point pre-test pain 
for testing session one to the BCTQ part two was found to be r= .661, p= .053, n= 9. The pre-test 
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pain correlation for testing session two was found to be r= .857, p= .002, n= 10. Although testing 
session one correlation between the two instrument measures was marginally significant, the 
results suggest that when a participant’s pre-testing CTS pain is high, it can be expected that 
their level of difficulty with ADLs will also be high. Since the two measures (pain and difficulty 
with ADLs) converge, this outcome provided some construct-related evidence of validity. 
 
All participants. For testing session one, when correlating 10 point Likert scale pre-test 
 
pain measures to the BCTQ part two, the Pearson’s correlation was found to be r= .801, p< 
 
0.001, n= 18. For testing session two, the Pearson’s correlation was r= .911, p< 0.001, n= 19. It 
was expected that the correlation would increase when non-CTS participants were included. 
Significant correlation results, however, suggested that the two measures converge. That is, 
participants’ pre-testing pain symptoms can assist in predicting their current difficulty in 
performing ADLs. 
 
Table 6 
 
Construct-related Validity 10 Point Pre-pain to BCTQ Part 2 
 
Participants r p n 
CTS, session one .661 .053 10 
CTS, session two .857 .002 10 
All, session one .801 < 0.001 18 
All, session two .911 < 0.001 19 
 
Evidence of face validity. Due to the low number of individuals with CTS, qualitative 
and quantitative measures were completed to assess the degree to which participants felt 
symptom aggravation after the administration of the CCT to provide further evidence for the use 
of question two as validity criteria for the CTCAT. Qualitative measures revealed that when 
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assessing the individual responses to question 2, “at any time after the testing session, did your 
CTS symptoms increase? If so, please describe the symptoms and duration of aggravation”, 
some participants experienced their CTS symptoms after leaving the testing. After the 
administration of the CTCAT, one participant from the CTS group data set reported, “I had latent 
 
numbness in my thumb tip and long finger that lasted an hour”. Another participant from the 
CTS group who did not have decompression surgery also reported, “On my drive home, my 
symptoms came on within a minute after leaving. They lasted 5 minutes, and then went away”. 
When these participants were questioned further about the severity of their symptom onset and 
whether or not the symptoms were worsened the next day, both participants stated that their 
symptoms lasted between 5-60 minutes. The descriptive, inferential and qualitative analysis 
results provide some evidence of face validity to use question 2 as a criterion for the validation 
of the CTCAT measures. 
 
To support the qualitative measures, descriptive and inferential statistics analyses were 
conducted and depicted in Table 7. For the CTS only participants, the mean pre-test pain score 
from the 10 point Likert pain scale for testing session one, M= 2.90, SD= 1.663, was lower than 
the post-test pain score mean, M= 4.10, SD= 2.283. For testing session two, the pre-test pain 
score mean, M= 3.20, SD= 2.098, was also lower than  the post-test pain score mean, M= 4.20 
SD= 2.150. 
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Table 7 
 
Pre-test and Post-test Pain Descriptive Statistics   
 
Participants M SD 
CTS, session one pre 2.90 1.663 
CTS, session one post 4.10 2.283 
CTS, session two pre 3.20 2.098 
CTS, session two post 4.20 2.150 
Non, session one pre 1.0 0.0 
Non, session one post 1.11 0.33 
 
Non, session two pre 
 
1.0 
 
0.0 
 
Non, session two post 
 
1.11 
 
0.33 
 
Inferential statistics (t-test) revealed a significant difference in the scores for pre-test pain 
in comparison to post-test pain for the CTS participants group in regards to testing session one 
t(9)= -3.087, p= .013.  For testing session two, the CTS group results computed were also 
marginally significant t(9)= -2.236, p= .052. When the same tests were completed for the non- 
CTS participant group, testing session one results provided non-significant differences t(8)= - 
1.00, p= .347. Testing session two, t-test results also showed no significant differences t(8)= - 
 
1.00, p= .347 between pre-test and post-test. The outcome of the statistical analysis supported 
the qualitative measures, as shown in Table 8. That is, the pain symptoms were aggravated for 
those individuals with CTS during the administration of the CCT. 
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Table 8 
 
Comparison of Pre-test Pain to Post-test Pain on 10 Point Scale 
 
CTS Participants t score p 
 
Session one t(9)= -3.087 .013 
 
Session two t(9)= -2.236 .052 
 
Non-CTS Participants 
 
Session one t(8)= -1.00 .347 
 
Session two t(8)= -1.00 .347 
 
 
 
Test of normality for 10 point Likert pain scale. A Shapiro-Wilk’s test (p> .05) (Shapiro & 
Wilk, 1965; Razali & Wah, 2011) showed that the 10 point Likert pain scale scores were 
approximately normally distributed for both the pre-test and post-test pain for testing session 
one. For the pre-test pain, skewness was found to be 0.337 (SE = 0.687) while kurtosis was 
found to be -0.447 (SE = 1.334); and a skewness of -0.013 (SE = 0.687) and a kurtosis of -1.473 
(SE = 1.334) was found for the post-test pain. 
 
For testing session two, the pre-test pain skewness was found to be 0.665 (SE = 0.687) 
while kurtosis was found to be -0.471 (SE = 1.334); and, a skewness of -0.406 (SE = 0.687) and 
a kurtosis of -1.201 (SE = 1.334) was found for the post-test pain. The outcome of this test 
confirmed that the data collected from the 10 point Likert pain scale fell within the normal 
distribution curve. 
 
Research Question Three- To what extent is the CTCAT able to assess CTS when 
compared to the BCTQ and 10 point self-report Likert pain scale? 
 
To address the third research question, evidence of reliability and validity are provided 
for the CTCAT by using intraclass correlations and Pearson’s moment correlations. Construct- 
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related evidence of validity is provided by correlating time measures of the CTCAT physical test 
to the change in pain (pre-test pain subtracted from post-test pain) scores for the 10 point Likert 
pain scale measures for session one and two independently. As the non-CTS group reported no 
change in pre- to post-test pain, this group was excluded from this part of the statistical validity 
analysis. 
 
Evidence of reliability for the CTCAT. Table 9 depicts these results. 
 
 
Non-carpal tunnel syndrome participants. To analyse this part of the question, an 
intraclass correlation for the measures of time was conducted between session one and two. As 
there was no noted change in testing time observed between the two testing sessions, this group 
was excluded from this part of the statistical analysis. 
 
Carpal tunnel syndrome participants. The intraclass correlation for the measures of time 
between session one and two was r= .906, p< 0.001, n= 10.  This high reliability result suggested 
that it is possible to reproduce the participant time to symptom onset measures across 
replications when using the CTCAT. 
 
 
All participants. The intraclass correlation for the measures of time between session one 
and two when including all participants revealed that for this data set, the correlation value was 
r= .932, p< 0.001, n= 19. It was expected that the correlation value would increase due to the 
inclusion of non-CTS participants in the data who did manifest changes in measures of time 
during the test. High reliability results, however, support the use of the CTCAT across 
replications when measuring time to CTS symptom onset. 
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Table 9 
 
CTCAT Reliability   
 
Participants r n 
CTS .906 10 
All .932 19 
 
Note: p< 0.001 
 
Construct-related evidence of validity for the CTCAT measures. Convergent-related 
and discriminant-related evidence of validity are included in Table 10 and provide evidence for 
the use of the CTCAT time measures as an assessment technique for CTS diagnosis. 
 
Convergent-related evidence of validity.  Table 10 shows these results. 
 
 
Carpal tunnel syndrome participants. Pearson's moment correlation revealed that the 
measure of pain during the test when using the 10 point Likert pain scale for testing session one 
significantly and negatively correlated to testing time, r= -.925, p< 0.001, n= 10.  For testing 
session two, however, the Pearson’s moment correlation revealed a marginally significant 
moderate correlation between the 10 point Likert scale measures of pain during the test and time 
to symptom onset,  r= -.574, p= .082, n= 10. Moderate correlation for session two may be related 
to participants’ variability on symptom onset based on their ADLs conducted during the day. 
This outcome, however, provides some convergent-related evidence of validity when relating the 
CTCAT measures to the 10 point Likert pain scale. That is, high participant pain during the test 
(the result produced by subtracting the participant pre-test pain from their post-test pain) is 
expected to produce a small measure of time to symptom onset. 
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All participants. When conducting the Pearson's moment correlation analysis for all 
testing participants, the results for testing session one provided significant correlations between 
time to symptom onset and pain during the test; r= -.922, p< 0.001, n= 19. For testing session 
two, the Pearson’s correlation was r= -.651, p= .003, n= 19; this was expected to be higher than 
the CTS data set because it included non-CTS participants who did not manifest changes in pain 
and time during the test. Since the CTCAT measures of time to symptom onset correlated to the 
measures of pain during the test when using the 10 point Likert scale pain measures for either 
CTS participants or all participants, this outcome provided some convergent-related evidence of 
validity for the possible use of the CTCAT times measures in CTS diagnosis. 
 
Table 10 
 
Convergent Validity for CTCAT   
 
Participants r p n 
CTS, session one -.925 .001 10 
CTS, session two -.574 .082 10 
All, session one -.922 .001 19 
All, session two -.651 .003 19 
 
Discriminant-related evidence of validity for the CTCAT. Table 11 and Table 12 
illustrate the results from this analysis. 
 
Carpal tunnel syndrome participants. For testing session one, Pearson’s correlation 
revealed no significant correlation between the BCTQ part one scores and participant testing 
time, r= .128, p= .724, n= 10.  For testing session two, the correlation was also found to not be 
significant, r= .017, p= .963, n= 10. When comparing the participant testing time to the pre-test 
data from the 10 point Likert Scale pain measures for testing session one, no significant 
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correlations were found for testing session one, r= -.097, p= .790, n= 10 and testing session two, 
 
r= .337, p= .341. 
 
 
All participants. Pearson’s correlation revealed no significant correlations when 
comparing the BCTQ part one score to the testing time for session one, r= -.326, p= .173, n= 19 
and session two, r= -.440, p= .059, n= 19. Similarly when comparing the  CTCAT measures of 
time during the test to the 10 point Likert scale pre-test pain measures, the results revealed no 
significant correlations for testing session one, r= -.376, p= .112, n= 19 and testing session two, 
r= -.105, p= .669, n= 19. This outcome provided discriminant-related evidence of validity due 
to the BCTQ part one and 10 point Likert scale pre-test pain measures assessing participant 
level of pain before each testing session, while the CTCAT served to assess pain differences in 
relation to time to symptom onset produced during the testing session. 
 
Table 11 
 
Discriminant Validity for CTCAT, BCTQ Part One   
 
Participants r p n 
 
CTS, session one .128 .724 10 
 
CTS, session two .017 .963 10 
 
All, session one -.326 .173 19 
 
All, session two -.440 .059 19 
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Table 12 
 
Discriminant Validity for CTCAT, 10 Point Scale Pre-test   
 
Participants r p n 
 
CTS, session one -.097 .790 10 
 
CTS, session two .337 .341 10 
 
All, session one -.376 .112 19 
 
All, session two -.105 .669 19 
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CHAPTER FIVE- DISCUSSION 
 
 
The results of the current study are discussed in terms of theoretical and empirical 
rationales to provide evidence of reliability and validity for the use of the CTCAT measures as a 
technique to assess CTS. Prototype development will be covered first, followed by the first three 
sections that contain a discussion of the results for each research question. The remaining four 
sections contain discussions about limitations of the study, conclusions, recommendations, and 
future directions. 
 
Prototype Development 
 
 
Developing a new assessment tool requires much thought and consideration. It also 
requires a great deal of patience and ingenuity. Throughout the development of the CTCAT, 
there were many issues that arose both before and during the pilot testing. As the device was 
created from scratch, with no other design plans to model the device after, it took quite some 
time to come up with a working prototype that could be used to carry out the CTCAT testing. 
 
The initial design process for the CTCAT took roughly one month of discussion between 
the researchers to come up with a functional unit. The initial prototype was too simple, and 
would not have let the pressure be applied steadily for the required testing time. It did not have a 
quick-release strap or a pressure pad to lock the wrist in place and maintain the pressure for the 
length of testing. The initial prototype design was thrown out, and a new design was created. The 
new prototype then had a quick-release strap that also acted as a restraint strap during the testing 
to allow the pressure to be applied steadily over the testing period. To apply pressure to the wrist 
space, an inflation pad, pressure gauge, and pressure ball were added to the device. This 
modification, in combination with the addition of the quick-release strap, allowed pressure to be 
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applied evenly and steadily for the duration of the testing. Small trial tests were then completed 
where the wrist of the researcher was inserted into the device for the allotted testing time to 
ensure that the pressure would stay steady and that the device would not open during testing. 
After the researchers were satisfied with the new CTCAT prototype, a pilot study was completed 
to test the function of the device. 
 
After the device design was finalized and a prototype was constructed, pilot testing was 
then completed. A design flaw was quickly noted once data collection for the pilot was 
underway, causing issues with how the pressure was being applied to the carpal tunnel space. 
This flaw was addressed, with proper modifications made to the device, and data collection then 
carried out. Once the pressure ball flaw was sorted out, testing ran smoothly with no more issues 
encountered along the way. 
 
Research Question One- How reliable are the measures obtained from the BCTQ with the 
current data? 
 
Boston carpal tunnel questionnaire inter-item reliability. According to Sambandam et 
al. (2008), the BCTQ developed by Levine et al. (1993) is the most commonly used outcome 
measure in the assessment of patients with CTS. Levine et al. (1993) found that the inter-item 
reliability scores for the two scales (the SSS and FSS) of the BCTQ were highly reproducible 
generating Cronbach’s alpha reliability scores of r= 0.91, n= 38 for the SSS and r=.93, n= 38 for 
the FSS. Although the inter-item reliability scores from the current study appear to be higher 
than the scores stated in the literature, the difference may be attributed to sample size. For 
example, the study by Levine et al. (1993) used a sample size of 38 participants with CTS, while 
the current study used a sample size of 10 participants with CTS and nine participants without 
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CTS. Lack of variability from the non-CTS participants may have impacted the inter-item 
reliability scores and increased the correlation value; thus, the small sample size for participants 
with CTS in this study might have affected the results. The data gathered from the current study 
for each administration of the BCTQ, however, supports the literature as the results are similar to 
those found by Levine et al. (1993); that the BCTQ measures are reproducible and contain a high 
degree of internal consistency when using these items to assess individuals with CTS. 
Boston carpal tunnel questionnaire test/retest reliability. Intraclass correlation scores 
for part one of the BCTQ, which measured participant level of pain felt in the last 24 hours were 
assessed by comparing the scores produced between first and second administration of the test. 
The strength of the relationship between the pre- and post-test measures can be used as an 
indicator of the variance present when repeating the measure (Bonett, 2003). The scores 
observed between the first and second administration of the BCTQ test in the current study 
revealed minimal variance, supporting the literature that suggests the level of pain reported by 
participants on the BCTQ part one was consistently measured between the two administrations 
of the test. It is also possible that the pain scores for the CTS only participants vary on a day to 
day basis, which can lower the intraclass reliability scores produced across replications of the 
instrument measures. To account for this variability, it may be necessary to administer the test 
more than twice. Reliability scores for the CTS only group were slightly lower than the “all 
participants” group, which may be attributed to the inclusion of the non-CTS participants in the 
intraclass correlation analysis who did not manifest change in pain symptoms across replications 
of the test. 
 
Intraclass correlation scores for the BCTQ part two, which measured participant level of 
difficulty with ADLs in the last 24 hours, were also computed using a similar approach as part 
57  
one of the BCTQ. High reliability scores suggest that the BCTQ produced consistent results with 
regards to participants’ difficulty with functional ADLs between the first and second 
administration of the test. This outcome supports the literature, which states that reliability is 
concerned solely with how test scores are expected to vary when repeatedly using the assessment 
tool (Haertel, 2006). 
 
As the CTS participants’ level of pain may vary on a daily basis, their abilities to perform 
functional ADLs such as buttoning a shirt or twisting a bottle cap off can also vary. To overcome 
this variability issue, it may be necessary to increase the number of replications of the test. It is 
interesting, however, that the intraclass correlation scores produced for part two of the BCTQ are 
slightly higher than the intraclass correlation scores for the BCTQ part one. This outcome may 
suggest that the participants’ perceived level of pain on testing days may vary slightly more than 
their perceived level of difficulty with certain daily functional tasks. 
 
The test of normality for the BCTQ confirms that the scores provided on both sections 
(functional status scale, symptom severity scale) fell within the normal distribution curve. This 
supports the notion that the data provided by the BCTQ is parametric in nature. 
 
In conclusion, the inter-item and intraclass reliability analyses in the current study 
provided consistent results for part one and two of the BCTQ. These outcomes support the 
literature (Bonett, 2003) and indicate that the BCTQ measures produce reliable results to be used 
as validity criteria for further analysis. Similarly, the strength of the relationship across 
replications of the measures can be used as an indicator of the variance present when repeating 
the measure.  Since the scores of this questionnaire were shown to be consistently reliable not 
only within testing sessions, but also between testing sessions, there is a strong evidence to 
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suggest that the inferences made from the test score interpretations of the BCTQ consistently 
measure pain and difficulty with certain daily functional activities as found in previous studies 
(Sambandam et al.,2008). 
 
Research Question Two- Can a 10 point self-report Likert pain scale question be used to 
assess CTS when compared to the BCTQ? 
 
In order to develop a criterion to measure the amount of pain produced during the 
CTCAT test for further validation of the CTCAT as a CTS diagnostic tool, it was crucial to 
provide evidence for the validation of the 10 point Likert pain scale. This approach was 
necessary because the BCTQ does not provide measures of pain during the administration of the 
test, but rather measures of pain symptoms and difficulty with ADLs within 24 hours before the 
administration of the CTCAT. To provide evidence for the validation of the 10 point Likert pain 
scale, the concept of validity by Messick (1989) was used, which states that “validity is an 
integrated evaluative judgment of the degree to which empirical evidence and theoretical 
rationales support the adequacy and appropriateness of inferences and actions based on test 
scores or other modes of assessment…it is important to note that validity is a matter of degree, 
not all or none” (p.13). Messick addressed the word integrated, which, in his concept of validity, 
referred to the summation of many sources of information based on the existing evidences and 
the interpretation of test scores. In the current study, empirical evidence and theoretical 
rationales in combination with different sources of information were used to validate the 10 point 
Likert pain scale measures and included concurrent-related, construct-related, and face-related 
evidence of validity. 
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Evidence of reliability of the 10 point Likert pain scale found through testing enables the 
use of this measure as validity criterion for further analysis. As stated by Kane (2006), the 
inferences made from test scores interpretations cannot be claimed as evidence of validity if the 
test scores are not proven to be reliable. 
 
Ten point Likert pain scale reliability. To assess the reliability of the 10 point pain 
Likert scale, intraclass correlation analyses were conducted that compared the pre-test pain 
scores for testing session one to the pre-test pain scores for testing session two. Strong to 
moderate significant intraclass correlation coefficients revealed consistency across replication of 
the scale. Over the two testing sessions, the Likert pain scale scores for the CTS participants, 
non-CTS participants and all participants groups were found to be significantly reliable. The 
outcome supports the reliability literature, which is solely concerned with how test scores are 
expected to vary when repeatedly using the assessment tool (Haertel, 2006). As expected, the 
results were highly reliable for the non-CTS participants who did not experience symptoms of 
pain throughout the test and moderately reliable for the CTS participants who experienced 
different levels of pain due to their CTS. Some of the variability or inconsistencies for CTS 
participant across replications of the test can also be attributed to those CTS participants who did 
not have decompression surgery and potentially had less tolerance to pain. 
 
Ten point Likert pain scale concurrent validity. According to Standards for 
Educational and Psychological Testing (1985), concurrent-related evidence of validity is “the 
degree to which the criterion information obtained from a sample of items, tasks, or questions on 
a test relate to the same criterion information obtained from a standard when both measures are 
obtained simultaneously” (p. 10). For this study, concurrent-related evidence of validity was 
provided by comparing the 10 point Likert pain scale pre-test pain measures to the BCTQ part 
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one (symptom severity) measures when the two assessments were administered simultaneously. 
The similarity between the two instrument measures was assessed by first putting the two 
instrument pain measures under the same scale and conducting intraclass correlations analyses 
for both testing sessions. 
 
Strong significant correlation between the two instrument pain measures provided 
construct-related evidence of validity for the use of the 10 point Likert scale as an instrument to 
measure pain related to CTS. While the comparison only involved the 10 point Likert scale pre- 
test measures of pain and not the post-test measures, this approach was necessary because the 
BCTQ only measured pain discomfort for the last 24 hours and not during the administration of 
the CCT. Furthermore, comparing the BCTQ pain scores to the 10 point Likert scale post-test 
measures would not provide concurrent-related evidence of validity as CTS participant pain 
levels were more likely be increased due to the administration of the compression test causing 
differences in participant pain tolerance level. Significant correlation results, however, provided 
evidence for the use of the 10 point Likert pain scale as validity criteria to assess CTS pain for 
later analyses. 
 
Ten point Likert pain scale construct-related validity. In regard to construct-related 
evidence of validity, Standards (1985) states that the relationship to other variables is also 
another method that can be used to assess the degree to which the construct being measured (pre- 
test pain) consistently relates to external variables (difficulty with daily functional tasks). 
Construct-related evidence of validity can be divided into two categories, convergent and 
discriminant validity. In the current study, the 10 point Likert pain scale pre-test scores were 
compared to the BCTQ part two, which measured participant difficulty with performing ADLs in 
the last 24 hours before the administration of the CTCAT test. Since the difficulty with ADLs 
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was expected to correlate with the 10- point Likert scale pre-test pain measures, the outcome 
provides some convergent-related evidence of validity for the use of the 10 point Likert scale as 
a measure of CTS pain. That is, as the participant’s CTS pain increases, so does his or her 
difficulty with performing ADLs. In conclusion, the outcome of this analysis strengthened the 
concurrent-related evidence of validity found in the previous analysis for the use of the 10 point 
Likert scale as validity criteria to assess CTS measures of pain. 
 
Ten point Likert pain scale face validity. As the 10 point Likert scale is a newly 
developed assessment scale to be used as validity criteria to measure the participant pain during 
the administration of the CTCAT test, providing evidence of face validity was necessary to 
strengthen the overall validity of the 10 point Likert scale pain measures under theoretical and 
empirical rationales stated by Kane (2006) and Messick (1989). Evidence of face validity for the 
10 point Likert scale pain measures was provided by using qualitative and quantitative measures 
to assess the degree to which the 10 point Likert scale measured participant pain during the 
administration of the CTCAT physical testing. These outcomes were also supported by 
qualitative data, as two participants reported that they had CTS symptoms brought on after the 
testing session was completed. More specifically, one participant reported that the symptoms 
lasted one hour after the physical testing, while the other participant reported a five minute flare 
up after the test. The test of normality completed for the 10 point Likert pain scale confirms that 
the scores provided for both the pre- and post-test pain scores fell within the normal distribution 
curve. This supported the notion that the data provided by the 10 point Likert pain scale was 
parametric in nature. 
 
These results support the literature on the use of self-report pain measures as an avenue to 
measure and diagnose CTS (Jahedi & Mendez, 2012). The results also provide evidence for the 
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validation and use of the 10-point Likert scale as a measure of pain, based on the integration and 
summation of many source of information, which are grounded on empir ical and theoretical 
rationales developed by Messick (1989) and Kane (2006). 
 
Research Question Three- To what extent is the CTCAT able to assess CTS when 
compared to the BCTQ and 10 point self-report Likert pain scale? 
 
While self-report questionnaires measures such as the 10 point Likert scale and the 
 
BCTQ have the advantage that they can be easily implemented to capture participant information 
( e.g., pain measures)  (Jahedi & Mendez, 2012), the responses may contain a subjective source 
of bias that can affect the variance of the intended construct being measured (Vogt, Selvin, 
Widdowson, & Hulley, 1977). One avenue to minimize the degree of subjectivity as a source of 
noise embedded within participant responses when using self-report measures (e.g., pain 
measures) is to include direct measures (Michels, 1983; Reuben & Siu, 1990). Including direct 
measures in the assessment in conjunction with subjective measures creates a test battery of 
measures that minimize threats to the validity of the data (Reuben & Siu, 1990).  Based on this 
rationale, in the current study, a CTCAT was designed to minimize the subjectivity imparted by 
a medical professional when administering the CCT. The CTCAT was also designed to provide 
another source of evidence in CTS diagnostic when administering the CCT (Durkan, 1991). By 
using response time measures during the administration of the CCT in conjunction with self- 
report measures of pain, it may be possible to more accurately assess individuals with CTS. This 
approach was implemented based on the concept of validity, described by Kane (2006) and 
Messick (1989) and the research work of Love (2003). 
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To use the CTCAT as an additional source of evidence for CTS diagnostics when 
capturing participant information, it was crucial to provide evidence of reliability and validity of 
the CTCAT response time measures. As Love (2003)  stated, when there was a loss in sensory 
nerve supply due to compression of the median nerve in the carpal tunnel space, symptoms such 
as tingling, numbness, or clumsiness with the affected hand may be reported depending on the 
severity of the participants’ CTS symptoms on the testing date. That is, participants may require 
more time under compression to increase their CTS symptoms and stop the physical testing. 
 
Carpal tunnel compression assessment tool reliability.  Based on Love’s (2003) 
rationale, the reliability for the CTCAT response time measures was assessed by comparing the 
administration of the CCT for testing sessions one and two using an intraclass correlation. 
Highly significant reliability results in terms of intraclass correlation time scores suggest that 
over the two testing sessions, the amount of time that passed before the participants needed to 
end the physical testing was roughly the same. This outcome provided evidence of reliability for 
the use of the CTCAT response time measures across replications of the CCT. These results also 
support Love’s (2003) statement that in order to trigger participant CTS symptoms, compression 
of the median nerve must take place over time. 
 
Construct validity for the carpal tunnel compression assessment tool.  Construct- 
related evidence of validity allowed for the use of the CTCAT response time measures as a CTS 
diagnostic tool to be administered in conjunction with self-report measures of pain as a CCT 
clinical testing battery. That is, the degree to which the self-report pain measures based on 
empirical and theoretical rationales supported the inference made from the CTCAT response 
time measures in diagnosing CTS (Cronbach & Meehl, 1955). This outcome was accomplished 
by providing convergent and discriminant-related evidence of validity. 
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Convergent-related evidence of validity. Campbell and Fiske (1959) stated that 
convergent validity is the degree to which two constructs that are believed to be related, are in 
fact, related. In the current study, convergent-related validity was provided by correlating the 
response time measures to the amount of pain felt by the participant during the administration of 
the CCT. Higher negative correlations for the all participants group may be due to the inclusion 
of non-CTS participant in the data set, who did not reveal any pain symptoms during the 
administration of the test as expected. Regardless, these outcomes provide some convergent - 
related evidence of validity for the use of response time measures as an assessment technique for 
CTS. Moderate significant correlation scores for testing session two, however, may be due to the 
participants’ variability in daily pain symptoms as indicated by Love (2003). Furthermore, 
negative correlations between response time measures and self-report measures during the 
administration of the CCT indicated that as the participant amount of pain felt during the 
administration of the CCT increased, the response time to CTS symptom onset decreased, an 
outcome that supports the literature (Kane, 2006; Campbell & Fiske, 1959; Love, 2003). 
 
Discriminant-related evidence of validity. In order to claim that the CTCAT response 
time measures had strong evidence of construct-related validity to assess CTS when 
administering the CCT, it was necessary to provide discriminant-related evidence of validity, the 
degree to which measures that are believed to be unrelated are, in fact, truly unrelated (Kane, 
2006; Campbell & Fiske, 1959).  The current study hypothesized that the response time to 
symptom onset during the administration of the CCT would not correlate to measures of pain 
before the administration of the CCT. This hypothesis was formulated based on Love’s (2003) 
theoretical rationale, that in order to trigger a participant’s CTS symptoms, compression of the 
median nerve must take place over time. 
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Non-significant correlation results with the pain measures before the administration of the 
test indicated that the CTCAT response time measures depended only on triggering participant’s 
CTS symptoms by compressing the median nerve over time. This outcome supports Love’s 
rationale and this study’s hypothesis. It also provided discriminant-related evidence of validity as 
defined in the literature (Kane, 2006; Campbell & Fiske, 1959) for the use of the CTCAT 
response time as a valid measure to access CTS when combined with self-report measures of 
pain. 
 
In summary, the results of this study revealed that the CTCAT has construct-related 
evidence of validity and it seems to provide an avenue for health professionals to use simple 
measures of response time in combination with a 10 point Likert pain scale to assess and 
diagnose individuals with CTS. The result of this study also supports the notion that the CTCAT 
does, in fact, elicit CTS symptoms in participants who have not had CTS release surgery. 
 
Limitations 
 
 
The primary limitation on this study was the small sample size of participants with CTS. 
Initially, this study aimed to include 20-30 participants with CTS to the testing group, but 
recruitment for this testing cohort proved to be harder than originally thought. Although fairly 
large medical clinics were approached within the city, some professionals were either not 
interested in helping to recruit participants, or were not currently treating any patients in their 
clinics with CTS. The CTS sample size could have been expanded by attempting to recruit more 
participants through contacting and approaching a larger number of medical centers within the 
city of Thunder Bay. Although there was a fairly even number of male and female participants, 
and a diverse age range in the sample used, a larger cohort of participants with CTS would have 
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strengthened the correlation analyses used when providing evidence of reliability and validity of 
the instrument measures. 
 
A secondary limitation to this study was age matching. Although an attempt was made to 
match both gender and age as closely as possible, the age matching was not as close as it could 
have been. The average age of the CTS group was 46 years, while the average age of the control 
group was 34 years. Ideally, age matching could have been closer to create a more representative 
study sample. Age matching could have been monitored more closely during the data collection 
stage in order to balance the two testing cohorts. 
 
Strengths 
 
 
The primary strength to this study is the creation of the CTCAT. This study is the first of 
its kind to attempt to build an objective measuring instrument for assessing CTS to potentially be 
used in the clinical setting. Introducing a device like this to the healthcare system would greatly 
reduce wait times for CTS assessment and diagnosis, thereby increasing the effectiveness of 
clinical time spent on assessing and diagnosing the condition. Through development and testing 
of the CTCAT in this study, the results support the use of the device in potentially assessing and 
diagnosing CTS clinically. 
 
Future Research 
 
 
Future research in this area that included a larger sample size of participants with CTS 
would strengthen evidence of the reliability and validity of the CTCAT response time measures. 
With more participants comes a better statistical standpoint for future research, which could 
make it possible to create standards to assess the severity of the participants’ symptoms to a 
higher degree when using response time measures. Ultimately, using a system that accurately 
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determines whether or not the individual has mild, moderate, or severe CTS symptoms will help 
medical professionals use the appropriate modalities to better understand a patient’s true range of 
symptom severity encountered on a daily basis, and to treat the symptoms. 
 
Furthermore, future research should match participant age and gender more closely to 
increase validity measures of the CTCAT when being used to assess CTS. The CTS testing 
group should also not include participants with CTS who have had decompression surgery. 
Including participants with CTS who have had decompression surgery into the CTS testing 
group can skew results as these participants could potentially present as a healthy participant if 
their decompression surgery was successful. 
 
Another addition to future research would be to compare the measures of the traditional 
carpal compression test to the CTCAT to examine the degree to which the two testing measures 
differ from one another. Sensitivity and specificity could then be calculated fo r the CTCAT. 
 
It would be beneficial to ensure that CTS participants that are included in the study are 
accurately and reliably diagnosed with CTS through the use of a standardized regimen, such as a 
standard clinical exam and EMG/NCS testing wherever possible. Screening potential participants 
for future research in this way would limit the number of participants included in the CTS group 
who may have other hand and wrist complications other than CTS. Future research should focus 
on assessing time to numbness instead of time to pain, as pain can be a late finding when 
assessing CTS. Numbness is more generally the first symptom of CTS that an individual 
encounters. 
 
Another suggestion for future research is to examine the accuracy of the CTCAT in 
assessing and diagnosing CTS by including a number of other objective testing measures, such 
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as functional MRI, NCS, or EMG. Using functional MRI may provide an avenue to determine a 
more accurate response time to symptom onset by examining how the pain onset affects certain 
areas of the brain. Comparing the CTCAT to both NCS and EMG studies would also allow the 
researcher to gauge the degree of sensitivity and specificity of the device when assessing CTS in 
the clinical setting. This approach may provide stronger evidence of validity for the use of the 
CTCAT as a CTS diagnostic tool if it can be correlated to standardized objective testing 
protocols. 
 
An additional suggestion for future research will be to assess CTS individuals based on 
their chosen career path. If research participants were divided into career classes, such as desk 
jobs or manual labour jobs, the CTCAT testing may be able to also assess whether one type of 
job versus another produces more severe cases of CTS. This approach may be beneficial for 
employers and medical professionals to help people with appropriate ergonomics set ups and 
treatment modalities. 
 
Lastly, future research could look at adapting the CTCAT to be a more compact, portable 
tool. As the device prototype used for this study was the first model designed, it is larger than it 
could and should be. Future research could incorporate a more compact version of the CTCAT , 
potentially including automatic features as well. If the device was made to be more compact, it 
could then be more portable and easily transported. 
 
Implications 
 
 
The current study has implications for researchers, patients, and health professionals. The 
research findings from this study indicate that the BCTQ serves as a measure of pain for CTS 
based on ADLs and discomfort, but does not relate to pain due to nerve compression. This 
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study’s outcome, however, supports the use of self-report questionnaires in diagnosing and 
assessing CTS because it provides evidence of reliability and validity for the use of a simple 10 
point Likert pain scale specifically to assess CTS pain instead of pain at the upper extremities. 
The outcome of this study also revealed that using the CTCAT to elicit participant CTS 
symptoms and pain supports the research of Durkan (1991) and the findings put forth by Love 
(2003). As found through the current research, in order to cause a change in participants’ pain 
and symptoms, the median nerve had to be compressed for a period of time; in this case, no 
longer than 30 seconds. The use of the CTCAT also builds on the research of Durkan (1991) as 
the testing revealed that a steady, direct pressure roughly the size of the thumb pads held over the 
median nerve is required to reproduce a participant’s CTS pain and symptoms. When used on 
CTS participants who have not had decompression surgery, the CTCAT elicited symptoms in all 
testing participants on both testing occasions. 
The potential use of the device in the clinical setting does not completely support Reuben 
and Siu (1990), who stated that objective assessment measures may require more staff time and 
effort, resulting in higher operating costs. As the CTCAT physical testing can be carried out by 
one person, and is non-invasive, it could therefore reduce diagnostic and assessment wait times 
and costs associated with diagnosis and assessment of CTS. 
From the practical perspective, the outcome of this study provides an avenue for health 
professionals and patients to assess CTS symptoms with a simple technique composed of a 10 
point Likert scale pain questionnaire and a CTCAT with moderate to strong evidence of 
reliability and validity measures. As the device gives reliable results without being 
technologically complex, medical professionals could easily use it to assess and diagnose CTS in 
a clinic setting. Introducing a simple to use assessment tool to the healthcare system would 
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greatly reduce the wait periods associated with more complex objective testing measures such as 
 
NCS and EMG, improving the speed with which accurate CTS diagnoses can be made. 
 
In summary, this study provided evidence of reliability and validity measures for the use 
of the CTCAT as a potential clinical assessment tool for CTS. The results also support the use of 
a simple and easy-to-administer 10 point Likert pain scale to assess CTS during the 
administration of the CCT. These outcomes provide support for healthcare professionals and 
employer for the use of simple and inexpensive measures, as a potential clinical testing battery to 
assess individuals at risk for CTS or who have CTS. 
 
Conclusion 
 
 
This study examined the potential usefulness of the CTCAT for clinical settings to assess 
CTS when compared to the BCTQ and the 10 point Likert pain scale. The study was conducted 
because it is evident that a combination of subjective questionnaires and simply administered 
objective testing measures better diagnose CTS in the general population. As stated in the 
literature, the irritation of the median nerve at the carpal tunnel space produces CTS symptoms 
such as tingling, burning, general discomfort, and aching in the affected fingers (Atroshi et al., 
1999), which are problematic symptoms for individuals to perform their ADLs and work tasks. It 
was found that the CTCAT could then potentially be used to assess and diagnose CTS within the 
clinical setting due to the success rate observed when assessing those with CTS who have not 
had release surgery. 
 
 
This study found that the CTCAT measures, when combined with the 10 point Likert pain 
scale into a testing battery, produced strong evidence of validity; that is, the CTCAT response 
time measures to symptom onset were highly correlated to participant pain produced by 
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the compression of the median nerve when implementing the CCT. This outcome supports and 
builds on the work of Levine et al. (1993) and Durkan (1991) as it combined a more objective 
measure (the CTCAT response time) with self-report measures of pain (BCTQ, 10 point Likert 
pain scale). 
 
Finally, the CTCAT provides an avenue to minimize measurement error associated with 
the traditional administration of the CCT, which requires a health professional to carry out the 
test manually. As the device is controlled by an inflation pad and pressure gauge, the health 
professional guess work associated with how much pressure to place over the median nerve is 
completely removed. Based on this approach and outcome of the data, it can be stated that the 
CTCAT provides reliable and valid measures of the participants’ response time to symptom 
onset when administering the modified CCT. In conclusion, the CTCAT, when combined with a 
subjective pain measure, is able to assess individual CTS symptoms to give patients more 
accurate and consistent estimates on their current CTS symptom conditio n. 
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Carpal Tunnel Compression Assessment Tool 
 
 
 
 
 
 
 
 
The testing instrument is a portable testing device that is easy to set up and use. The device is a 
small box that has one opening for the hand of the participant. There is a hinged moving arm that 
is locked in place with a Velcro strap once the participant’s hand is in the proper testing position. 
Once the wrist has been rested on the sphygmomanometer bulb in the proper position, the wrist 
angle is adjusted through the use of an adjustable ball rest. On the bottom of the device, there is 
an inflatable bladder that presses on a sphygmomanometer bulb, which pushes on the median 
nerve area of the hand. The bladder is inflated by a hand pump, which the researcher controls. To 
monitor the pressure of the bladder, a small pressure gauge is attached. The sphygmomanometer 
bulb serves to compress the median nerve in the same fashion that the Carpal Compression Test 
does. If the participant feels uncomfortable at any time, the device can be opened immediately to 
free the hand by pulling the Velcro strap open. 
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Writing  2 3 4 5 
Buttoning dothes 1 2 3 4 5 
Holding a book wh ae reading 1 2 3 4 5 
Holding the teleph one hang   1 2 3 4 5 
Housekeeping  2 3 4 5 
Opening a glass vi al cap 2 3 4 5 
Carrying market b gs 1 2 3 4 5 
Bathing and dressi ng  1 2 3 4 5 
 
n 
Boston Carpal Tunnd Questionnaire 
 
 
 
ANNEX 1 
SELF-EVALUATIONPROTOCOL-BOSTON PROTOCOL 
Name:.......................... ....... ..-................. ............................ 
RGHSP: ......... .... ................. Hand:( ) Right    (  ) Left 
Evaluation Date:.....J.....J.     Surgery Date: ...../.....J...... 
 
THE FOLLOWING QUESTIONS REFER TO  YOUR 
SYMPTOMS WITHIN A TYPICAL PERIOD OF 24 
HOURS, DURING THE LAST TWO WEEKS. 
(Oloose one answer in each question) 
1) How strong is the pain on your  hand or wnst at night? 
1- Ifeel no pain on hand or wrist at night. 
2-lrttle pain 
3- modefate pain 
4- intense pain 
5- severe pain 
2) How many t mes did your hand or wrist pain wake you 
upm a typical 
nighlfor thelast two weeks? 
t- never 
2-once 
3- twice or three times 
4- four to five times 
5- more than frve times 
3) Do you usually feet hand or wrist pain during the da'(? 
1- l never  feet paindur ng the day 
2- Ifeel little pain during the day 
3- Ifeel moderate pain during the day 
4·Ifeel intense pain during the day 
5- Ifeel severe pain dur ng the day 
4) How often do you feet hand or wrist pain during the da'(? 
1- never 
2- once or twice a day 
3- three to five lim!!$ a day 
4·more than live times a day 
5- constant pain 
5) In average, how long do daylime pain episodes last? 
1·Inever feet pain during the day 
2- less than 10 minutes 
3- from 10 to 60 minutes 
4- more than 60 minutes 
5- Ifeel constant pain during the day 
6) Do you feel your hand dormant (lost sensitiveness)? 
1·no 
2- 1 feel little dormancy 
3- Ifeel moderate dormancy 
4·Ifeel intense dormancy 
5- Ifeel severedormancy 
Do you feet weakness on your hand or wriSI? 
1·no weakness 
2- litUe weakness 
3- moderate weakness 
4·intense weakness 
5- severe weakness 
8) Do you  feel a bnghng sensation on your hand? 
1- no tingling sensation 
2- little tin g ing sensation 
3- moderate tingling sensati on 
4- 1ntense tingling sensabon 
5·severe t ngling sensation 
9) How strong is dormancy (lost sensitivity) or 
tingling sensation at night? 
1- I never  feel dormancy o r ting  ng sensation 
at night 
2-little 
3·moderate 
4- intense 
5- severe 
10) Howoften did dormancy or tinging sensation 
wake you up during a typical  night for the last twO 
weeks? 
1- never 
2- once 
3- twice to three times 
4• four to frve times 
5- more than five times 
11) How difficult do you  feel in taking and using 
smallobjects. such as keys or pens? 
1- not diffiCUlt 
2- a litUe difficult 
3- moderately d fficult 
4- very difficult 
5·severely difficult 
INA TYPICALDAY FOR THE LAST TWO WEEKS, 
HAVE YOUR HAND OR WRIST SYMPTOMS 
BROUGHTANY DIFFICULTY INPERFORMING 
THE ACTIVITIES LISTED BELOW? 
Please.circle the number that  best  describes 
your ab  ity  to perform theactivity. 
 
DEGREE OF 
ACTIVITY DIFFICULTY 
 
 
 
 
 
 
 
a 
 
 
No difficulty ....................................................   . 1 
Little difficulty.................................................... 2 
Moderate difficulty ........................................... 3 
Intense difficulty ............................................... 4 
Cannot perform the activity at all due 
to hands and wrists symptoms........................ 5 
 
Investigator's opinion: ........................................ 
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Appendix C: Carpal Compression Test 
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Carpal Compression Test 
 
 
 
 
 
The Carpal Compression Test was invented and tested in 1991 by J. A. Durkan. The test is a 
physical test that focuses on compression of the median nerve with the thumbs. A pressure of 
150mmHg is applied to the carpal tunnel space for a maximum of 30 seconds, in attempt to 
reproduce the patient’s CTS symptoms. If the patient’s symptoms come on before the 30 seconds 
has passed, the physical testing is ceased. Original testing used a sphygmomanometer inflation 
bulb attached to a blood pressure cuff pressure gauge (left picture). This method was used to 
ensure a constant pressure of 150mmHg was used. However, current Carpal Compression 
Testing is completed through use of the testing professional’s two thumbs (right picture). Testing 
completed this way leads to large individual difference in perception of pressure and the size of 
an individual’s thumb pad. 
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Appendix D: Recruitment Poster 
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Attention Clinic Patients 
 
 
 
 
 
 
 
 
 
 
Do you have Carpal Tunnel Syndrome? 
 
 
 
 
 
 
 
 
 
 
 
 
 
Would you like to take part in a quick study in regards to 
your condition? 
 
 
 
 
 
 
 
If you would like to take part in this quick study, please 
consult your health care provider to get more 
information about this study 
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Appendix E: Participant Recruitment Form 
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Name: 
Carpal Tunnel Study Recruitment Form 
 
 
 
 
 
Phone Number: 
 
Email: 
Signature: 
Date: 
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Appendix F: Healthcare Professional Cover Letter 
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Appendix G: 10 Point Likert Pain Scale 
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Perceived Level of Pain/Discomfort 
 
 
 
 
 
 
Please rate your pre-test pain and/or discomfort in your wrists 
 
 
 
 
1 2 3 4 5 6 7 8 9 10 
 
No/limited pain Worst pain ever 
 
 
 
 
 
 
 
 
 
 
 
Please rate your post-test pain and/or discomfort in your wrists 
 
 
 
 
1 2 3 4 5 6 7 8 9 10 
 
No/limited pain Worst pain ever 
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Appendix H: Control Participant Consent Form 
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Appendix I: Carpal Tunnel Syndrome Participant Consent Form 
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